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Résumé 
 
Au Canada, nous remarquons une prédominance du diabète de type 2 au sein des 
communautés autochtones. Une approche ethnobotanique est utilisée en collaboration avec 
la Nation Crie de Eeyou Istchee afin de déterminer quels traitements à base de plantes 
peuvent être utilisés pour contrer les différentes conditions qui, collectivement, forment le 
diabète. Les pharmacopées de deux communautés cries, soit celles de Waskaganish et de 
Nemaska, ont été établies puis comparées à celles de étudiées antérieurement : 
communautés Whapmagoostui et Mistissini. Malgré les différences géographiques de ces 
groupes, leurs utilisations sont  majoritairement semblables, avec pour seule exception le 
contraste entre les communautés de Nemaska et de Whapmagoostui.  
 
De plus, nous avons complété l’évaluation du taux cytoprotecteur des aiguilles, de 
l’écorce et des cônes de l’épinette noire (Picea mariana). Les extraits provenant de tous les 
organes des plantes démontrent une protection qui dépend de la concentration. La réponse 
spécifique d’organes peut varier selon l’habitat; ainsi, les plantes poussant  dans les 
tourbières ou dans les forêts, sur le littoral ou à des terres l’intérieur démontrent des 
différences quant à leur efficacité. Bref, l’écorce démontre une relation dose-effet plus forte 
dans la forêt littorale, tandis que les aiguilles n’indiquent pas de changements significatifs 
selon leur environnement de croissance. La bioactivité observée démontre une corrélation 
avec le contenu phénolique et non avec l’activité de l’agent antioxydant. Ces résultats 
contribuent à péciser les activités antidiabétiques des plantes de la forêt boréale canadienne, 
telles qu’identifiées au niveau cellulaire par les guérisseurs Cries. 
 
Mots-clés 
 
Plantes médicinales, Diabète de Type II, Neuropathie, Picea mariana, ethnobotanique, 
agent antioxydant, phénol, cytoprotection, Autochtones, Premières Nations, cellules PC12-
AC 
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Abstract 
 
In Canada there is an overwhelming prevalence of type II diabetes in First Nations 
communities. Here an ethnobotanical approach has been used in cooperation with the Cree 
Nation of Eeyou Istchee to focus on finding plant based treatments for the conditions which 
collectively make up the symptoms of diabetes. The pharmacopoeias of two Cree 
communities (Waskaganish and Nemaska) are elucidated then compared with previously 
studied populations (Whapmagoostui and Mistissini). Despite differences in north-south 
east-west geography, plant ranking and use matrices were similar with the exception of 
Nemaska/Whapmagoostui.  
 
We have also completed the evaluation of Black spruce (Picea mariana) needle, 
bark and cone cytoprotectivity.  Extracts from all organs exhibited concentration-dependent 
protection. Organ-specific response was habitat and growth environment dependent with 
plants grown either in bog or forest habitats in coastal or inland environments exhibiting 
differences in efficacy. Observed bioactivity correlated with total phenolic content but not 
with antioxidant activity. Together, these results contributed to the understanding of 
antidiabetic activity of Canadian boreal forest plants identified by the Cree of Eeyou 
Istchee healers at the cellular level. 
Keywords 
 
Medicinal plants, Type II Diabetes, Neuropathy, Picea mariana, Ethnobotany, Antioxidant, 
Phenolics, Cytoprotection, aboriginal, PC12-AC cells 
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An Introduction to Diabetes in Aboriginal Populations 
 
1.1 Introduction to Diabetes 
Diabetes is a group of metabolic disorders that affect glucose uptake (Health 
Canada, 2002). Although the disease manifests itself in many forms, three main categories 
exist: type I, type II, and gestational.   
 Type I diabetes is mainly a genetic disorder and is normally diagnosed 
during childhood. In this case, the beta cells of the pancreas are attacked by the 
autoimmune system, causing irreversible damage and ceasing the production of insulin. 
Without insulin, glucose cannot be readily transported from the blood into the insulin 
sensing cells, which leaves the afflicted person hyperglycemic. Left untreated, the disease 
quickly becomes fatal (Health Canada, 2002). Patients with type I diabetes require insulin 
injections in order to control their blood sugar. Complications such as neuropathy, 
nephropathy and retinopathy arise from increased oxidative stress. It is estimated that only 
10% of all diabetes cases are of this category. This is true for the overall Canadian 
population and specifically for aboriginal communities, so when we refer to a diabetes 
epidemic we are referring to type II which represents 90% of all diabetes cases (Health 
Canada, 2000). Gestational diabetes which only affects pregnant women is also a major 
problem in first nation communities; however, the condition is considered temporary and is 
not part of our focus.  
 Type II diabetes results from the development of insulin resistance in target tissues, 
mainly the muscle and liver cells (Health Canada, 2002). As a result, insulin levels in 
afflicted individuals can be either abnormally high if beta cells are compensating for 
lowered sensitivity, or if at a later stage of disease progression, abnormally low since the 
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beta cells become exhausted. High blood sugar above 7mmol/L is characteristic of type II 
diabetics (Meltzer et al., 1998). Symptoms of type II diabetes include arthritis/rheumatism, 
frequent headaches, back and/or kidney pain, diarrhea, swelling and/or inflammation, 
general weakness, increased appetite, heart and/or chest pain,  increased thirst, abscesses 
and/or boils, blurred vision, increased urination, foot numbness and/or foot sores, slow 
healing infections, and sore and/or swollen limbs (Leduc et al., 2006). These symptoms and 
related complications are the parameters that will be used in order to identify medicinal 
plants that could be used for the treatment of diabetes in this study.  
 Symptoms and complications of type I and type II diabetes are caused by the stress 
placed on the microvascular and macrovascular systems from oxidative damage due to 
hyperglycemia (Schultz Johansen et al., 2005). Although it is possible to regulate blood 
glucose levels with conventional treatment options, it is difficult for most. Fluctuations can 
lead to damage of the kidneys, eyes, nerves, heart and blood vessels (Rahimi et al., 2005). 
The result can be as severe as blindness, renal failure, cardiovascular disease, loss of 
feeling or tingling in the extremities and/or the development of slow healing sores which 
can only be treated by amputation. Insulin injection therapy is sometimes employed in 
severe type II cases; however, for most this type of diabetes is controllable with the help of 
oral medication which increases insulin sensitivity and/or proper diet and an active 
lifestyle.  
1.2 Diabetes in Canadian Aboriginal Populations  
Aboriginal people in Canada suffer from higher rates of diabetes than the overall 
population and are considered one of the highest risk groups for diabetes in the world 
(Health Canada, 2000; Yu and Zinman, 2007). Waskaganish and Nemaska, are two of nine 
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Cree communities making up the Eeyou Istchee territory within Québec and have high rates 
of diabetes (18% and 17.5% respectively) (Kuzmina et al., 2008). Diabetes was virtually 
unknown in these  communities before the 1940s (Legaré, 2004). Prevalence remained low 
through the 1980’s when it reached 5.2%. By 1991, 7.1% of the population was diagnosed 
with diabetes, and now the age standardized prevalence is 25% (Kuzmina et al., 2008). 
High rates of complications are also characteristic of these populations. For example, in 
2002 a study was conducted in which 58% of participants suffered from kidney problems, 
11% from retinopathy, 12% from neuropathy and 13% had some form of vascular 
complication (Legaré, 2004). The rapid increase in prevalence among Canadian First 
nations has been attributed to a genetic predisposition towards obesity and diabetes, and a 
shift towards a Westernized lifestyle. 
1.3 Genetic Predisposition 
The trend towards a sedentary lifestyle and poor diet is becoming a global problem 
and certainly a Canadian one; however, the consequences are magnified in indigenous 
populations where there is a genetic predisposition for weight gain and type II diabetes. 
Scientists believe that aboriginals have what are termed “thrifty genes”(Neel, 1999; Yu and 
Zinman, 2007).    
 Theoretically, thrifty genes help to maintain fat reserves and are leftover from a 
time when our ancestors lived a life of feast and famine as hunter gatherers (Ritenbaugh 
and Goodby, 1989). In times when food was plentiful, a person with such a genetic makeup 
would easily store fat despite physical activity and this was viewed, and still is to some 
degree, as being healthy among many communities (Boston et al., 1997; Neel, 1999; 
Ritenbaugh and Goodby, 1989). When a period of famine came, often during the winter, 
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those with excess energy stores would survive while those without were at greater risk of 
starvation. With this lifestyle, there is a genetic selection over time towards a “thrifty” 
metabolism. Nowadays there is no threat of famine and activity levels are reduced since the 
acquisition of food involves a simple trip to the grocery store (Boston et al., 1997; 
Chakravarthy and Booth, 2004; Ritenbaugh and Goodby, 1989). For aboriginal populations, 
the ability to store fat efficiently is no longer a benefit but a burden. 
 Genetic predisposition to obesity is polygenic and therefore highly complex, 
making the attribution of specific genes or pathways difficult (Hegele et al., 2003). One 
gene specific to the Oji-Cree, called HNF1A, has been identified. It encodes for a 
transcription factor which acts on an insulin production gene. It is not the wild type HNF1A 
gene that has the thrifty characteristics however; it is when the gene possesses the G319S 
mutation found in the Cree population that the phenotype is created (Hegele et al., 2003).  
 The G319S mutation was found in Northwestern Ontario and Manitoba populations 
of Oji-Cree (Hegele et al., 2003). The presence of this mutation was strongly correlated to 
the development of diabetes and could be used quite accurately to predict whether an 
individual would develop diabetes by the age of 50. Although the identification of such a 
marker is interesting, 60% of diabetics in this population did not have the mutation, 
providing evidence that there are several genetic factors at play. Furthermore, without an 
environmental stress, individuals with the mutation could have been free of diabetes. This 
is possible because the mutation confers only a reduction in the activity of the transcription 
factor rather than eliminating all of its function. In agreement with others, it is concluded 
that the additional stress comes from poor diet and a lack of exercise, resulting in obesity 
(Hegele et al., 2003). 
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1.4 Perception of Diabetes – The Roadblocks 
In general, First Nation communities consider diabetes to be a disease originating 
from the “Whiteman”, like tuberculosis and other disease epidemics that came with the 
arrival of Europeans (Young et al., 2000). They blame the increasing numbers of diabetes 
cases on the consumption of “Whiteman’s food” and the adoption of a sedentary, non-
nomadic lifestyle, spent mostly on reserves (Boston et al., 1997). Scientists recognize that 
the traditional diet of bush food did not contain refined carbohydrates, unlike the fast and 
processed foods of a modern Westernized diet (Gittelsohn et al., 1996). Hence, if it is the 
incorporation of processed foods and the trend towards a sedentary lifestyle imposed by 
modern values that are to blame, it is counterproductive to cure the disease with what is 
perceived to be "Whiteman's" foods, lifestyle regimens and medicine. In this situation the 
development of recommendations that incorporate traditional food and medicinal practices 
would be beneficial.  
Aboriginal communities are divided in their perception of traditional and modern 
medicine. Among the older generation there is a general distrust of Western foods and 
medicines (Gittelsohn et al., 1996). Younger generations, on the other hand, seem to be 
losing their trust in traditional medicine and are becoming increasingly interested in modern 
conveniences. There is a need for compromise and flexibility in medical/medicinal 
treatment for these populations (Letendre, 2002). Difficulty in understanding treatment, 
incompatibility with lifestyle, lack of medical treatment and medical facilities can all 
contribute to what has been seen as low compliance to modern medicine. This all translates 
to a very high incidence of resulting microvascular and macrovascular complications 
(Legaré, 2004). 
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 According to the Aboriginal Peoples Survey (APS), in 1998 over 90% of diabetic 
aboriginals had seen a health care provider within the year. This demonstrates interest in 
and utilization of modern medicine in these communities. However, a First Nations and 
Inuit Regional Health Survey (FNIHS) found that more than 80% of diabetic aboriginals 
felt that the health care system was in need of improvement. Main concerns were the lack 
of staff, chronic care facilities, home care, education about medication, disease prevention 
and mental health counseling (Young et al., 2000). 
 A 1998 study in Milwaukee, Wisc, surveyed Native Americans  using urban health 
care centers and the largest groups represented were Ojibway (20.7%), Oneida (20.0%), 
Chippewa (11.3%), and Menominee (8.0%) (Marbella et al., 1998). Of the surveyed 
patients, 38% were seeing a healer in addition to a physician. Most of the patients went to 
the healer for spiritual reasons, highlighting a need for a more holistic approach to 
medicine. This is reiterated when 86% of patients not seeing a healer responded that they 
would consider it in the future. The types of healers sought out were spiritual (50.1%), 
herbalist (42.1%) and medicine men (28.1%) (total exceeds 100% since some patients 
sought out more than one kind of healer). Of those who saw both a physician and a healer 
only 14.8% told their physician, and of those who did not tell their physician it was because 
they felt physicians would not understand, would want too many details or would not 
believe in the healer’s abilities. Patients who received different recommendations from their 
healer than their physician had a difficult time deciding what medicines to take and how, 
but most often valued their healer’s advice the most (Marbella et al., 1998). Studies such as 
these clarify the shortcomings of urban medical treatment facilities, mainly highlighting a 
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need for holistic methods that can incorporate all aspects of aboriginal life in a culturally 
sensitive way.  
1.5 Benefits of Plant Based Medicine 
For Canadian aboriginals, traditional medicine refers to the medical practices 
established before European colonization, which brought new diseases and Western 
medical influences (Johnston, 2002). Religious conversion has also brought changes in the 
utilization and delivery of traditional medicine (Niezen, 1997). This is because, unlike 
Western medical practices, traditional medicine is rooted in spiritual belief. For this reason, 
the increasing disinterest in traditional practices among aboriginal youth will undoubtedly 
continue to influence changes in the spiritual aspect of traditional treatment methods. 
Although much change is expected, an ongoing interest in plant and animal based treatment 
methods will likely remain as this type of treatment has been resilient even throughout the 
conversion of the Hudson’s Bay Cree (Niezen, 1997).  
 Arnason et al. (1981) summarize plants used for food and medicine by aboriginals 
of eastern Canada. More than 400 plants were listed as being used medicinally, and of those 
105 were identified as having known biochemical constituents with medicinal potential. 
Monoterpenes, polyacetylenes, alkaloids, tannins and salicylates are among the most 
frequently identified as medicinal constituents, many of which are found in conifers that are 
characteristic of the boreal landscape where our study area is found (Arnason et al., 1981).  
 In recent ethnobotanical surveys of northern Quebec, James Bay Cree and Inuit 
populations, many of the plants identified by Arnason et al. (1981) were reported to have 
anti-diabetic potential (Fraser et al., 2007; Leduc et al., 2006). Sixteen plants from 
Mistissini and 20 plants from Whapmagoostui were used for the treatment of diabetes 
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symptoms. All of these plants have been tested for their antioxidant potential and many 
have notable activity. Interviews by Leduc et al. (2006) and Fraser et al. (2007) revealed 
that plant part, preparation and selection are all important in order to ensure usefulness of 
plant medicines. An in vitro study on Picea glauca (Moench) Voss, a species closely 
related to Picea mariana (Mill.) Britton, Sterns & Poggenb. (a major focus of this thesis), 
has shown that symptom specific responses of plant extracts (neuropathy) are possible in 
the treatment of diabetes (Harris et al., 2008). In this case, differences in the plant part used 
were proven to affect activity in agreement with elder recommendations.  
Despite having a multitude of conventional treatment options, diabetes 
complications remain common (Health Canada, 2002). This is due, in part, to the fact that 
conventional treatments target a specific metabolic aberration while the disease is 
characterized by having several (Tiwari and Rao, 2002). Crude plant extracts could be more 
beneficial due to the synergistic effects of phytochemicals found in these preparations. 
Plants that could reduce oxidative damage, restore the health of beta cells, increase insulin 
secretion, increase sensitivity to insulin, mimic insulin and control blood glucose levels or 
combinations of these would be interesting. Some examples of plants with anti-diabetic 
properties exist and can be found as part of traditional pharmacopeias around the world 
(Marles and Farnsworth, 1995; Tiwari and Rao, 2002).    
 One way in which plants can be beneficial is by providing antioxidants (Ames et al., 
1993; Soumyanath, 2006).  It is generally accepted that antioxidants provide overall 
protection against complications in diabetes and are beneficial for health in general. This is 
because the normal functioning of our metabolism produces reactive oxygen species (ROS) 
that damage lipids, proteins and carbohydrates. In a healthy individual the body produces 
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scavenger enzymes, that neutralize the harmful ROS (Ames et al., 1993). However, in 
diabetics the production of scavengers is insufficient and/or the amount of ROS produced is 
much higher than normal leaving the system overrun (Ames et al., 1993; Schultz Johansen 
et al., 2005). Many phenolic compounds like tannins have antioxidant activity and are often 
quantified to determine the potential level of protection a plant may have against ROS 
(Fraser et al., 2007; Spoor et al., 2006).  
 High antioxidant activity appears to be a common characteristic of Canadian 
aboriginal treatments for diabetes symptoms (McCune and Johns, 2002). As evidence for 
this, McCune and Johns compared plants used for three or more symptoms of diabetes to 
commonly consumed Western foods in Native communities. The majority (89%) scored 
higher than the Western food items in antioxidant studies, while 14% and 23% were on par 
with ascorbic acid and green tea/Trolox respectively (McCune and Johns, 2002).  
 Interestingly, it seems that plants with high levels of antioxidants can also be 
capable of increasing glucose uptake at the cellular level (Spoor et al., 2006; Tiwari and 
Rao, 2002). This may be due to the influence of ROS on specific regulatory molecules in 
the insulin dependent glucose transport pathway (Tiwari and Rao, 2002). ROS increases the 
expression of TNF-, a cytokine capable of inhibiting tyrosine phosphorylation of the 
insulin receptor and post receptor signaling intermediates. A lack of phosphorylization 
renders insulin incapable of stimulating glucose uptake via GLUT-4 (glucose transporter) 
causing hyperglycemia. In response to what is perceived as a lack of insulin, GLUT-4 is 
down regulated, decreasing its presence and further hindering glucose uptake (Tiwari and 
Rao, 2002). This is one way in which insulin resistance could be increasing over time in 
diabetics. In this case, increased hyperglycemia further increases ROS production, thereby 
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restarting the cycle (Tiwari and Rao, 2002). Some antioxidants, including polyphenols, 
have shown an ability to down regulate TNF- by reducing ROS. The synergistic properties 
seen in the James Bay Cree plants (antioxidant and glucose uptake) could be due to this 
type of protection (Spoor et al., 2006; Tiwari and Rao, 2002).  
 Besides increasing glucose uptake in insulin sensitive cells, antioxidants protect and 
may even help to restore beta cells in the pancreas (Chakravarthy et al., 1980). The health 
of alloxan-induced diabetic rat pancreases have shown improvement after treatment with 
Pterocarpus marsupium Roxb. (Fabaceae), an Ayurvedic medicinal plant (Chakravarthy et 
al., 1980). Similar results have been found for Gymnema sylvestre (Retz.) Schult. 
(Apocynaceae) in streptozotocin-induced diabetic rats (Tiwari and Rao, 2002).  
 Plants are also able to reduce the availability of glucose (Tiwari and Rao, 2002). 
Many reduce its presence by inhibiting carbohydrate hydrolyzing enzymes such as a-
amylase and a-glucosidase (Kim et al., 2000). Others reduce glucose uptake from the 
intestine by inhibiting S-GLUT-1 (Kobayashi et al., 2000). Furthermore, plants like 
Trigonella foecum-graecum L. (Fabaceae) can affect glucose availability by modifying 
gastric emptying (Srinivasan, 2006). In T. foecum-graecum, the fiber reduces the total 
amount of glucose taken up and slows its release, which prevents spikes in blood glucose 
levels (Chandalia et al., 2000).   
  Myrcia multiflora (Lam.) DC. (Myrtaceae) is a Brazilian medicinal plant that is 
commonly known as plant insulin (Tiwari and Rao, 2002). Contrary to its name, the plant 
does not act like insulin; instead, it limits the diabetic’s glucose absorption and therefore 
can prevent complications. Specifically, it is capable of inhibiting aldose reductase and a-
glucosidase. Inhibition of aldose reductase prevents damage from sugar accumulation like 
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what is typical in the diabetic lens (Tiwari and Rao, 2002; Yoshikawa et al., 1998). Like S-
GLUT-1, -glucosidase inhibition occurs in the intestine which prevents glucose absorption 
before it can cause complications (Yoshikawa et al. 1998; Tiwari and Rao 2002). This is 
yet another example of how medicinal plants could have multiple benefits. 
1.6 Environmental Influences 
 Crude plant extracts that offer multiple levels of protection, alone or in combination, 
would be of more benefit than a single target drug; however, fluctuations in the 
composition and concentration of beneficial compounds can be problematic. There are 
many factors associated with growth environment that may influence the phytochemistry of 
medicinal plants. Fluctuating compounds are ones involved in protecting against UV 
damage, herbivory, plant competition (allelopathy) or may be associated with different 
types of stress like waterlogging or drought (McCune and Johns, 2007). Other abiotic 
factors linked to climate or nutrient availability could also have an impact (Connor et al., 
2002; Estiarte et al., 1994; Wang and Zheng, 2001).   
 Although specific examples of environmental influence on antioxidant 
phytochemistry exist, most have been conducted on commercially available cultivars. In 
general, plants from Mistissini and Whapmagoostui have not been the focus of such studies 
with the exception of Vaccinium spp. (Leduc et al., 2006). In a two year study (1998, 1999, 
(Connor et al., 2002)) it was found that phenolic content in blueberries of the same cultivar 
varied significantly from location to location and year to year. From this, they concluded 
that differences in chemistry must be due to environmental influence. In this case 
antioxidant activity fluctuated in unison with phenolic content. This is a trend that has also 
been observed for several of the Cree antidiabetic plants (Spoor et al., 2006; Wang and 
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Zheng, 2001). One purpose of this study is to determine whether antidiabetic activities of 
Picea mariana could be influenced by its growing environment.  
1.7 Study Goal 
The overall goal of this study is to aid in recommending plants for use as traditional 
medicine in the modern facilities of First Nations communities. In order to succeed in 
making broad generalizations, the traditional medicine of four James Bay Cree 
communities will be compared. Similar histories of experience and the sharing of 
knowledge between communities increase the likelihood that their pharmacopoeias will be 
similar. Furthermore, ethnobotanical and phytochemical evidence support this (Arnason et 
al., 1981; Fraser et al., 2007; Holmes, 1884; Leduc et al., 2006; Marles et al., 2000; Marles 
and Farnsworth, 1995; Marshall and Chiskamish, 1996; Marshall et al., 1989; Seigfried, 
1994; Strath, 1903). Specifically, regression analysis of plant ranking from literature 
sources and Mistissini interviews showed positive correlation and Mantel and Podani 
algorithm results confirmed similarities (Leduc et al., 2006). Therefore hypothesis 1(H1): 
Although diversity in flora will vary from one community to the next, if locally available, 
plant use will remain consistent for the treatment of diabetes symptoms in all four 
pharmacopoieas. Differential activity for same species comparisons has, however been 
demonstrated by Fraser et al. (2007) for plants harvested from different communities. 
Namely antioxidant capacity of Larix laricina, Rhododendron groenlandicum and Pinus 
banksiana varied depending on whether they were grown in Whapmagoostui (north-
coastal) or Mistissini (south-inland).  
To ensure reliability of recommendations, environmental influence on antidiabetic  
activity will be further evaluated using P. mariana as a model plant. P. mariana has been 
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chosen for several reasons: 1. It grows in drastically different environments and is very 
plastic, having several growth forms, and it is often stunted in stressful environments like 
bogs (Begin and Filion, 1999; Kershaw, 2001; Legasy et al., 1995; Newmaster et al., 1997) 
2. It already has shown promise as an antioxidant (Fraser et al. 2007, Spoor et al. 2006); 3. 
A closely related species, P. glauca (Wang et al., 2000; Weng and Jackson, 2000) has 
shown promise as a protector against diabetic neuropathy in vitro (Harris et al., 2008).  
Hypothesis 2 (H2): In the nutrient-poor, waterlogged conditions of bogs (Zoltai and 
Vitt, 1995), where plants tend to be stunted (Kershaw, 2001), P. mariana will have more 
stress related compounds and therefore have a greater ability to protect PC12 cells from 
high glucose conditions.  
 Although the tandem use of traditional and conventional medicine is nothing new in 
developing countries (Bodeker, 2001), it is a novel approach to solving the problem of 
diabetes in Canadian aboriginal communities. We hope at the completion of this study to 
provide evidence that more culturally specific treatment recommendations are possible.    
 The results of this study are divided into two main chapters. Chapter 2: examines 
the findings of our ethnobotanical study and chapter 3 focuses on P. mariana bioactivity. In 
Chapter 2, we present the plants that were mentioned for the treatment of diabetes 
symptoms in Waskaganish and Nemaska. Plants are ranked using a syndromic importance 
value and then all TAAM interviewed communities are compared and contrasted using the 
Spearman rank analysis, Mantel analysis and Podani algorithm. Relationships between 
plants and specific symptoms are explored using correspondence analysis.   
 In chapter 3 we evaluate P. mariana’s ability to prevent glucose toxicity in PC12-
AC cells in vitro (a diabetic neurophathy model). Protective activities are detailed for 
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needle, bark and cone taking the influence of growth environment into account. Regression 
analysis is used to determine if there are correlations between phenolic content, antioxidant 
activity and bioactivity. Conclusions based on these findings are drawn in the fourth and 
final chapter where we explore P. mariana’s prospective use as a sustainable resource for 
diabetes treatment.  
16


 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Ethnobotany 
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An Ethnobotanical Approach to Finding Culturally Appropriate Treatment Options 
for Canadian Aboriginals Suffering From Diabetes: Inter and Intra-specific 
differences in Medicinal Plant Use 
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Abstract 
 In order to identify plants with potential to treat the multiple symptoms of diabetes 
we surveyed local knowledge of two Eeyou Istchee Cree communities located in northern 
Quebec and made comparisons of plant use with two communities interviewed previously. 
Forty elders and healers from Waskaganish and Nemaska were surveyed using a semi-
structured approach. Two plants previously unrecorded were identified: Heracleum 
maximum Bartram and Thuja occidentalis L.. Thirteen plants were confirmed between the 
two surveys and were ranked based on their potential to treat diabetes using the syndromic 
importance value (SIV) and the frequency of citation (FC) method for each community. 
The SIV ranking was then calculated compiling data across communities including the 
previously surveyed populations of Mistissini and Whapmagoostui. The degree of 
correlation between ranking of common plants was then measured using the Spearman rank 
test. Nemaska/Mistissini, Waskaganis/Whapmagoostui, and Mistissini/Whapmagoostui had 
correlation values >0.5 and were deemed similar. In the Mantel analysis, used to compare 
plant use matrices, there was a lack of correlation between communities with the exception 
of the Waskaganish/Nemaska comparison. Conversely, the Podani algorithm showed 
similarities between matrices in all cases except the Nemaska/Whapmagoostui comparison 
which agreed with the Spearman test results. Symptom species associations were also 
evaluated for the two new communities and for all communities grouped as one population. 
In the overall evaluation, among several associations, it was only Abies balsamea (L.) Mill 
(that was associated with the vision symptom) that was mentioned in more than one 
community. Other associations in the overall correspondence analysis were Juniperus 
communis L. (Whapmagoostui) and Lycopodium clavatum L. (Mistissini) for urination 
problems and Vaccinium vitis-idae L. (Whapmagoostui) for vision problems. The plants 
mentioned therein should be tested for their ability to treat associated symptoms in 
vitro/vivo bioassays to further TAAM’s goal of finding traditional plant based remedies for 
diabetes treatment.       
18


2.1 Introduction 
Diabetes is a chronic disease capable of afflicting people from all walks of life and 
is expected to affect 366 million individuals by 2030 (Wild et al., 2004). Although, the 
problem is global, it impacts indigenous groups more dramatically (Yu and Zinman, 2007);  
Canadian aboriginal populations have a threefold higher prevalence of diabetes as 
compared to the national average (Health Canada, 2000; Young et al., 2000; Yu and 
Zinman, 2007). This represents a dramatic increase in the disease as it was not present in 
First Nation populations less than 100 years ago. The diabetes epidemic has been attributed 
to the acculturation that took place during European colonization and therefore to a 
changing lifestyle (Boston et al., 1997; Chakravarthy and Booth, 2004; Health Canada, 
2000; Robinson et al., 1995). The Québec Cree of Eeyou Istchee are particularly affected 
by this, leaving 1 in 4 with type II diabetes (Kuzmina et al., 2008). Researchers and health 
care professionals agree that the problem of diabetes must be dealt with immediately. 
Participatory research in Cree communities has revealed that lifestyle 
recommendations and treatments in modern facilities are often culturally inappropriate 
(Boston et al., 1997; Johnston, 2002). This leads to low levels of compliance resulting in 
higher levels of more severe complications including neuropathy, nephropathy, retinopathy 
and morbidity (Young et al., 2000). The CIHR Team in Aboriginal Antidiabetic medicine 
(TAAM) is a multidisciplinary group of researchers and community members working on 
this problem. The team is focused on incorporating plant based medicine from local 
traditional practices into modern health care facilities in Eeyou Istchee communities. 
Plants have been used for millennia to treat diabetes in places like China, India and 
Egypt (Oubré et al., 1997). The incorporation of traditional and alternative medicine into 
the modern framework is a natural progression in developing countries; however, in 
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Canada it is a novel approach (Bodeker, 2001). Based on phytochemical and ethnobotanical 
evidence we believe that boreal plants are capable of treating diabetes, but that a short 
history of the disease has not allowed for the manipulation of plants for this purpose. 
Therefore, boreal antidiabetic medicine is essentially in its infancy and needs to be 
promoted. 
The use of an ethnobotanical approach ensures that treatments are not simply herbal 
but also culturally appropriate (Oubré et al., 1997). Surveys for the TAAM project were 
initially conducted in Mistissini and  Whapmagoostui (Fraser et al., 2007; Leduc et al., 
2006). Although many plants were mentioned and tested from the first two locations it was 
important to invite other communities to join the project. The two newly participating 
communities, which are the topic of this paper, are Nemaska and Waskaganish. Allowing 
them to share their knowledge offers an opportunity to identify new plants and to compare 
pharmacopeia use between all interviewed communities. Comparisons can serve as a tool in 
determining which plants are appropriate for use in a particular community. Since the 
availability of local plants is relatively consistent in Nemaska and Waskaganish, we predict 
that their use will be similar. Furthermore, we expect that similar histories of experience 
and knowledge sharing have led to comparable plant use between all of the Eeyou Istchee 
communities surveyed. Therefore, Spearman rank tests, Mantel tests and Podani algorithm 
analysis comparing plant importance and use should agree, showing that SIV values and 
matrices are similar. We surmise that in many cases symptom specific links between plants 
found through correspondence analysis will also be reflected in the literature. This 
consultation of the literature will serve as a cross reference in determining the importance 
of plants for the treatment of diabetes symptoms.   
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2.2 Materials and Methods 
2.2.1 Ethnobotanical Survey 
Waskaganish and Nemaska are two of nine Eeyou Istchee Cree communities in the 
north of Quebec (Beaulieu, 1998). Waskaganish is a small community of approximately 
2,045 occupants located at the mouth of the Rupert River and has access to James Bay. 
Nemaska is inland on Lake Champion and is the second smallest of the communities 
having around 680 inhabitants (MSSS, 2009). Both communities are at similar latitudes 
within the 51rst parallel. Previously similar studies have been done in Mistissini (South) and 
Whapmagoostui (North) located at the 50° and 55° N parallels respectively (Beaulieu, 
1998).  
Interviewees were identified by community members as being particularly 
knowledgeable in herbal medicine. Interviews began in June and took place in the home of 
willing participants. The average age of participants was 74 yrs in Waskaganish and 68 yrs 
in Nemaska, although some elders could not remember their age or were not willing to 
share this information. Two younger knowledgeable participants, namely two Cree culture 
teachers, took part as well (one from each community). Couples in general preferred to be 
interviewed together and were therefore counted as n=1.   
The survey was the same semi-structured questionnaire that had previously been 
used by Leduc et al. (2006) and Fraser et al. (unpublished) in the communities of Mistissini 
and Whapmagoostui. The survey is structured around 15 symptoms of diabetes and its 
complications: (1) arthritis/rheumatism, (2) frequent headaches, (3) back and/or kidney 
pain, (4) diarrhea, (5) swelling and/or inflammation, (6) general weakness, (7) increased 
appetite, (8) heart and/or chest pain, (9) increased thirst, (10) abscesses and/or boils, (11) 
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blurred vision, (12) increased urination, (13) foot numbness and/or foot sores, (14) slow 
healing infections, and (15) sore and/or swollen limbs. Surveys and methods were approved 
by the Université de Montréal ethics comity, “Comité d’éthique de la recherché de la 
faculté des arts et des sciences (CÉRFAS) (see appendix I). During the interview process 
we obtained prior informed consent; Cree Elders and Healers were aware that they could 
decline or stop the interview at any time and that they did not have to answer all questions. 
Interviews were recorded following the agreement of the Elder or Healer. Three voucher 
specimens of each plant cited in the interviews were collected and used to confirm the 
identity of the plants mentioned. Specimens were deposited in the Marie-Victorin 
herbarium (MT)(Appendix VIII and VIIII).  
2.2.2. Ranking 
Two methods of ranking were employed: the syndromic importance value (SIV, 
(Leduc et al., 2006)) and the frequency of citation calculation (FC, (Ladio and Lozada, 
2004)). The syndromic importance value was calculated for each plant in order to assign a 
ranking order for the comparison of the plants relative importance as a potential diabetes 
treatment. It is also used to compare pharmacopoeias among communities and to rank all 
species from TAAM surveys as one overall population. Sphagnum moss and lichen species 
were not included as their identification was not clear. The SIV was calculated using the 
equation below,
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where “ ws” is the sum of the weight of all the symptoms for which the plant was 
mentioned (for example, if it was mentioned for 15 symptoms, then ws=1). “wf” is the 
sum of the symptom weight multiplied by the number of times it was mentioned for that 
use, “F” is the total number of interviews, while “S” is the number of symptoms in the 
survey (i.e. 15)(Leduc et al., 2006). 
 The FC was used as a second method of ranking for comparison. Ranks were 
calculated for each plant by dividing the “# of interviews in which the plant was 
mentioned” by “the total # of interviews” (Ladio and Lozada, 2004).  
2.2.3 Statistics – Comparing Communities 
A Spearman rank correlation test was used (Biostats program) to measure how 
similarly plants ranked between communities (ie. Waskaganish vs Nemaska, Waksaganish 
vs Whapmagoostui, Nemaska vs Whapmagoostui, Nemaska vs Mistissini, Waskaganish vs 
Mistissini and Mistissini vs Whapmagoostui). This analysis was only performed on SIV 
results since the FC calculation gave equal ranking to many plants. To perform this 
analysis, plants that were not common to both communities were removed from the list. 
Since gaps in SIV ranking results from the removal of plants the list was re-ranked so that 
in both communities species would be ranked 1 – n (n = number of species in common) 
without skipping any number. To further expand comparisons, the Mantel test and Podani 
algorithm were used to evaluate matrix correlations. In the case of the Mantel test, 
Euclidian distance was measured taking simple presence/absence of species mention (1 or 
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0) into account for the 15 symptoms (10,000 permutations, R program). With the Podani 
algorithm, we have compared community plant use matrices which specify the number of 
mentions for each plant and symptom. Podani correlations were calculated using Manhattan 
differences via 10,000 permutations of rows, columns, or both (Leduc et al., 2006). 
In order to understand the association between species and symptoms, we used 
correspondence analysis (R program). This analysis was represented visually by scatter 
plots for each community. 
2.3 Results 
2.3.1. Ranking 
In Waskaganish, 19 interviews were completed with a total of 25 participants. 
Twelve plants were listed, two of which, Heracleum maximum and Thuja occidentalis (see 
Table 2.1.), were new to the project. Picea glauca, Abies balsamea, Larix laricina (Du Roi) 
K. Koch, Picea mariana and Rhododendron groenlandicum (Oeder) Kron & Judd were the 
top five plants listed using the SIV ranking method. Ranking using the FC method of Ladio 
& Lozada (2004) placed Abies balsamea, Alnus incana ssp. rugosa (L.) Moench ssp. 
rugosa (Du Roi) R.T. Clausen, Larix laricina, Picea mariana and Populus balsamifera L. 
in the top five positions (see Table 2.2). Abies balsamea, Larix laricina and Picea mariana 
were in the top five for both methods whereas Picea glauca, Rhododendron goenlandicum, 
Alnus incana ssp. rugosa and Populus balsamifera were not common to both. 
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Table 2.2 Species mentioned by informants in Waskaganish in order of rank based on the 
FC method (Ladio & Lozada 2004). 
Species 
% 
Frequency Rank 
Abies balsamea 78.9 1 
Alnus incana ssp. rugosa 68.4 2 
Larix laricina 52.6 3 
Picea mariana 42.1 4 
Populus balsamifera 36.8 5 
Thuja occidentalis 36.8 5 
Rhododendron groenlandicum 26.3 6 
Heracleum maximum 21.1 7 
Picea glauca 21.1 7 
Pinus banksiana 15.8 8 
Sorbus spp. 5.3 9 
Saracenia purpurea 5.3 9 
  
P. glauca
A. balsamea
L. laricina
P. mariana
R. groenlandicum
P. banksiana
T. occidentalis
H. maximum
A. incana
P. balsamifera
S. purpurea
Sorbus spp.
0 2 4 6 8 10 12
Rank  
Figure 2.2 Bar graph depicting the differences in SIV (black) and FC ranking (gray) of the 
12 plants mentioned in Waskaganish. 
 
In the smaller community of Nemaska 15 interviews with 15 participants led to the 
identification of 10 plants, none of which were new from previous studies. Ranking was 
similar using both the SIV and FC method (see Tables 2.3. & 2.4 and Figure 2.3) for this 
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community. Interesting, however, is the position of Picea glauca as it falls from the first 
position in Waskaganish to the last in Nemaska.  
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Table 2.4 Species mentioned by informants in Nemaska in order of rank based on the FC 
method. 
Species 
% 
Frequency Rank 
Alnus incana ssp. rugosa 93.3 1 
Picea mariana 46.7 2 
Larix laricina 46.7 2 
Abies balsamea 40.0 4 
Populus balsamifera 26.7 5 
Rhododendron groenlandicum 26.7 5 
Pinus banksiana 20.0 6 
Sorbus spp. 13.3 7 
Picea glauca 13.3 7 
Kalmia angustifolia 6.7 8 
 
P. mariana
A. incana
L. laricina
A. balsamea
P. balsamifera
R. groenlandicum
P. banksiana
Sorbus spp.
K. angustifolia
P. glauca
0 1 2 3 4 5 6 7 8 9 10
Rank  
Figure 2.3 Bar graph depicting the similarity in SIV (black) and the FC ranking (gray) of 
the 10 plants mentioned in Nemaska. 
 
Thuja occidentalis, Heracleum maximum and Sarracenia purpurea L. were all 
uniquely mentioned in Waskaganish. Kalmia angustifolia L. was the only plant mentioned 
in Nemaska that was not mentioned in Waskaganish; however, this plant had been 
mentioned before in Mistissini (Leduc et al., 2006).  
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 When the interview data for all four communities are lumped together there are a 
total of 23 plants (table 2.5). After ranking the species of all four communities as a single 
sample, the top five plants are Rhododendron groenlandicum, Rhododendron tomentosum 
Harmaja ssp. subarticum, Larix laricina, Picea mariana and Picea glauca.  
Table 2.5 List of 23 plant species mentioned by informants in all surveyed communities 
and their SIV ranks. Zero represents plants that were not mentioned in that community. 
  Plant Ranks 
    Whapmagoostui Waskaganish Mistissini Nemaska 
1 Rhododendron groenlandicum 1 5 1 6 
2 Larix laricina 2 3 2 3 
3 Rhododendron tomentosum 3 0 0 0 
4 Picea glauca 4 1 14 10 
5 Picea mariana 5 4 4 1 
6 Kalmia angustifolia 6 0 12 9 
7 Juniperus communis 7 0 0 0 
8 Sorbus spp. 8 12 5 8 
9 Salix planifolia 10 0 7 0 
10 Vaccinium vitis-idaea 11 0 13 0 
11 Leymus mollis 12 0 0 0 
12 Pinus banksiana 13 6 9 7 
13 Empetrum nigrum 14 0 0 0 
14 Cladonia rangiferina 15 0 0 0 
15 Alnus incana spp. rugosa 0 9 6 2 
16 Abies balsamea 0 2 3 4 
17 Vaccinium angustifolium 0 0 11 0 
18 Lycopodium clavatum 0 0 10 0 
19 Gaultheria hispidula 0 0 15 0 
20 Sarracenia purpurea 0 11 8 0 
21 Populus balsamifera 0 10 0 5 
22 Thuja occidentalis 0 7 0 0 
23 Heracleum maximum 0 8 0 0 
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C. rangiferina
G. hispidula
E. nigrum
V. angustifolium
H. maximum
T. occidentalis
L. clavatum
P. balsamifera
L. mollis
S. purpurea
V. vitis - idaea
A. incana
S. planifolia
P. banksiana
A. balsamea
J. communis
K. angustifolia
S. decora
P. glauca
P. mairana
L. laricina
R. tomentosum
R. groenlandicum
0 0.005 0.01 0.015 0.02 0.025 0.03 0.035 0.04
SIV  
Figure 2.4 Bar graph representation of SIV ranking for all 23 plants. SIV’s were calculated 
after merging data from Waskaganish, Nemaska, Whapmagoostui and Mistissini, and 
treating the master dataset as information from one population. Plants are listed from the 
highest SIV to the lowest. 
 
2.3.2 Comparing Communities 
In order to determine whether plant use within the pharmacopoeias of the four 
communities were similar, several methods were employed. 
Spearman rank correlation test. Starting with the Spearman rank correlation test 
(see table 2.6), we find that Nemaska and Mistissini (r = 0.60) pharmacopoeias are the most 
similarly ranked, followed closely by Waskaganish and Whapmagoostui (r = 0.54) and 
Mistissini and Whapmagoostui (r = 0.52). Nemaska and Whapmagoostui have some 
similarity in ranking (r = 0.29) while Waskaganish and Mistissini are not well correlated (r 
= 0.13). Unexpectedly, Waskaganish and Nemaska are not similarly ranked at all (r = 0.05). 
However, for Wakaganish/Nemaska and Waskaganish/Mistissini, a lack of correlation may 
in part be due to the position of Picea glauca. In Nemaska and Mistissini this plant is  
ranked 10th and 14th respectively and in Waskaganish it is number one. If you remove this 
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species from the analyses the correlation coefficient increases to r = 0.4286 
(Waskaganish/Nemaska) and r = 0.6190 (Waskaganish/Mistissini), which means they are 
very similar. In the case of the Spearman rank correlation test we are using the plant’s 
importance as determined by the SIV ranking method. The SIV takes the weight of the 
symptoms into account distinguishing it from the other two methods of comparison (ie. 
Mantel test and Podani algorithm). 
Mantel test. When analyzing matrices which have been simplified into mention 
(value = 1) or lack of mention (value = 0) for the Mantel test, we find that only 
Waskaganish and Nemaska have similar plant use (r=0.5773, p=0.0002). All other matrix 
comparisons gave p values well over 0.05 meaning that they are no more similar than two 
matrices randomly generated. 
Podani algorithm. This changes, however, when we look at the Podani analysis 
which takes the frequency of mentions into account. For all but one community 
comparisons, p values were smaller than 0.05 meaning that the matrices were significantly 
similar when compared to matrices randomly generated. The only comparison that was not 
found similar was the Nemaska/Whapmagoostui relationship and this agrees with 
Spearman results.  
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2.3.3 Symptom-Species Associations 
For the sake of clarity, all outliers and clusters obtained from the correspondence 
analysis were included in tables 2.7 and 2.8. However, for the discussion of relationships, 
we will limit our definition to plants being mentioned more than one time for a given 
symptom. In Waskaganish, Populus balsamifera and Alnus incana ssp. rugosa stood out as 
treatments for abscesses and/or boils. Abies balsamea, Picea mariana, Heracleum 
maximum and Larix laricina all come out as being associated with the treatment of 
infection. Abies balsamea was also closely linked in this community to problems of blurred 
vision. With only two mentions, Picea glauca was connected to the treatment of heart 
and/or chest pain. Thuja occidentalis was also coupled with this symptom and is considered 
strongly linked since it had six mentions. Finally, Rhododendron groenlandicum was 
associated with urination problems, one of the most heavily weighted symptoms by 
physicians in our survey with two mentions in Waskaganish.  
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Table 2.7 Symptom-species associations revealed as a result of analyzing two dimensional 
perceptual maps (see figure 2.5 and 2.6, appendix II & III) stemming from the 
correspondence analyses of Waskaganish and Nemaska contingency tables. 
 
Plants Symptoms # mentions 
Waskaganish    
P. balsamifera abscesses/boils 7 
A. incana ssp. rugosa abscesses/boils 13 
P. banksiana inflammation 1 
A. balsamea infections 8 
P. mariana infections 7 
H. maximum infections 3 
L. laricina infections 7 
A. balsamea vision problems 9 
P. glauca heart/chest pain 2 
T. occidentalis heart/chest pain 6 
T. occidentalis headache 1 
R. groenlandicum urination problems 2 
Nemaska    
P. glauca headache 2 
A. incana ssp. rugosa arthritis/rheumatism 1 
A. incana ssp. rugosa inflammation 1 
A. balsamea vision problems 5 
L. laricina infections 6 
P. mariana foot sores 1 
Sorbus spp. diarrhea 1 
R. groenlandicum urination problems 1 
P. balsamifera urination problems 1 
P. banksiana heart problems 1 
 
In Nemaska, corespondance analysis was less valuable because there were fewer 
plants which were also mentioned less frequently. Many symptom-species associations 
occurred when plants were uniquely mentioned for that symptom (see table 2.7). Picea 
glauca, however, was linked to the treatment of headaches with two mentions, while Larix 
laricina was connected to the healing of infections. Like in Waskaganish, Abies balsamea 
was repeatedly mentioned for the treatment of blurred vision and correspondence analysis 
confirmed that relationship (see table 2.8).  
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In the overall analysis of all four communities Abies balsamea; Lycopodium 
clavatuem, Juniperus communis and Vaccinium vitis-idaea stood out but in this case as 
plants associated with urination problems. With the exception of Abies balsamea all 
associations were unique to a given community; that is, when an association was observed 
it occurred only in that community and not in any of the other three. 
Table 2.8 Symptom-species associations revealed as a result of analyzing two dimensional 
perceptual maps (figure 2.7, see appendix IV) stemming from the correspondence analyses 
of the merged contingency tables of all four communities (Whapmagoostui, Waskaganish, 
Mistissini and Nemaska). Species outliers and the symptom they were associated with are 
mentioned here with specific identification of the communities in which the species were 
actually mentioned. 
 
Species Symptom Communities(#mentions) 
L. clavatum urination problems Mist(2) 
J. communis urination problems Whap(34) 
A. balsamea vision problems Mist(10), Wask(9) and Nem(5) 
V.vitis - idaea vision problems Whap(15) 
 
2.4 Discussion 
With the exception of Heracleum maximum, Thuja occidentalis and Saracenia 
purpurea in Waskaganish and Kalmia angustifolia in Nemaska, all plants were common to 
both communities surveyed in this study. This represents shared knowledge which is likely 
the result of a similar history of experience. Differences in pharmacopoeia, are highlighted 
by the Spearman rank, Mantel test and Podani algorithm and represent underlying 
distinctions between compared communities. Here we suggest that discrepancies between 
the Podani algorithm and the Spearman rank correlation results is due to the position of 
Picea glauca. Picea glauca’s relative importance as determined by ranking was also not 
agreed upon using the SIV (first place) and FC (seventh place) methods.  
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  During interviews in Waskaganish, Picea glauca was described as being close to 
the coast or river edges. Since Waskaganish is a coastal community, it is likely that this 
community is surrounded by a higher density of this tree species as compared to Nemaska, 
an inland population. This ranking trend is mirrored when looking at Picea glauca in 
Whapmagoostui, a coastal community (rank = 4) and Mistissini, an inland community (rank 
= 14). In both Nemaska and Mistissini, inland communities, this plant is present but ranked 
last. Since the ranking of P. glauca was affected by a difference in species distribution and 
abundance we re-calculated the Spearman rank coefficient for Waskaganish/Nemaska and 
Waskaganish/Mistissini comparisons. Removing P. glauca resulted in a strong correlation 
for these comparisons (r = 0.4286 and r = 0.6190).  
If we look at the geography and the history of these communities this level of 
correlation makes sense. These communities are not only in proximity to one another but 
there was also a period of time when Nemaska residents set up camp in neighbouring 
communities including Waskaganish and Mistissini. Their relocation was prompted by the 
James Bay Hydro-Electric Project and the closing of the Hudson's Bay Company fur 
trading outpost (Nemaska, 2009). The sharing of knowledge during this period represents a 
horizontal transmission of information and may also account for the similarity of plant use 
highlighted by the Spearman and Podani analyses (Heinrich et al., 1998). In this 
comparison the Mantel test did not show a significant amount of correlation (p = 0.2643) 
but this may be due to the fact that, given the number of zeros in our matrices, the analysis 
was not a good fit. The number of zeros in the matrices is in part due to the fact that many 
plants are not used for multiple symptoms. For example if a plant is used by both 
communities but only for one symptom that leaves 14 zeros in each matrix. A small number 
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of participants particularly like what we had in Nemaska can have the same effect. 
Unfortunately another compounding factor could be a loss of knowledge with respect to 
plant based medicine for these symptoms. It was also apparent that some symptoms used in 
the interview process such as loss of appetite and general weakness were considered the 
result of a hard days work and were “cured” with the consumption of food. Therefore these 
conditions were not thought of as symptoms to any disease and in their case would 
represent an area in the matrices where a lack of citation would be represented as a zero 
result. We see similar results for Whapmagoostui/Waskaganish and 
Whapmagoostui/Mistissini comparisons where it is only the Mantel test that does not show 
similarities. It is possible that in cases where there are a large number of zeros that it is not 
possible to determine if the two matrices are similar with simple presence/absence data. In 
comparing Nemaska and Whapmagoostui we see no similarities in plant use using any of 
the statistical manipulations.  
It is important to take into account that we have only considered plants that are 
common to both communities being compared using these statistical methods. Plants that 
were not mentioned by both communities under comparison represent unique aspects of 
their pharmacopoeias relative to one another. In some cases like with P. glauca it could be 
a lack of presence or abundance that results in no citation. In order to elucidate unique 
attributes within their pharmacopoeias floristic surveys would have to be conducted for all 
four communities. In the case of Saracenia purpurea, absence of the species is the main 
reason for its lack of citation in Whapmagoostui due to its distribution (Forest and Legault, 
1977). The same is true for Thuja occidentalis, which is reaching its northern limit in the 
Waskaganish area. Conversely, Rhododendron tomentosum ssp. subarticum likely only 
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grows in Whapmagoostui and not in the more southern communities (Cuerrier, personal 
communication). On the other hand, where distribution is not a factor, it is simply that these 
groups do not use the same plants in the same way (Johns et al., 1990). 
When considering all four communities a total of 23 plants have been identified and 
ranked, two of which were newly mentioned, Heracleum maximum and Thuja occidentalis. 
In general, the importance of top ranking plants remained after pooling all four 
communities. One unexpected result came when looking at R. tomentosum ssp. 
subarticum’s rank before pooling in the Whapmagoostui dataset (3rd position) and after 
pooling (2nd position). When this plant was ranked taking all datasets into account it 
actually placed higher overall despite its lack of mention in the other communities. This is 
likely due to the fact that this plant was mentioned for all symptoms at least once and in 
more than five out of fifteen cases mentioned by >10  participants. A large number of 
mentions for this plant shows that this information is common knowledge within 
Whapmagoostui and that it is considered a powerful plant and likely a cure all. P.glauca 
ranks 5th overall despite the fact that it ranked in last place for both Mistissini and 
Nemaska. Its strength is likely attributable to its tie with the treatment of slow healing 
infections and foot sores, which were heavily weighted symptoms by physicians in the 
development of the SIV calculation.   
In comparison to the FC ranking we believe the SIV gives a richer picture. The FC 
method, which was used for the two communities in question but not for the overall 
ranking, is based only on the number of times the plant has been mentioned by informants. 
It does not take into the account the relation of the symptoms to the disease. In general the 
SIV is likely a better method for identifying plants which have the most potential in treating 
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this specific disease. However, the usefulness of this calculation seems to be dependent 
upon the population size and amount of information acquired from it. In Waskaganish the 
SIV rank gave us a slightly different picture than the FC whereas in Nemaska the results of 
the two methods are comparable.   
Since, for the most part the four communities have similar uses of plants, we will 
now compare and contrast what is already known about the use of plants by the Cree for the 
treatment of diabetes symptoms (see table 2.9). If we consider the results from our 
correspondence analysis, starting with Sorbus species which was linked to the diarrhea 
symptom (Nemaska), we find that it is also mentioned in the literature. This reinforces the 
link made in the survey. It also corroborates the use of Thuja occidentalis and Picea spp. 
(Picea glauca in our study) for heart and/or chest ailments. Populus balsamifera was used 
for treating abscesses and/or boils just as was found in Waskaganish. The strong correlation 
between vision problems and the use of Abies balsamea in the overall correspondence 
analysis was reiterated in the literature as well(Marshall et al., 1989). Rhododendron 
groenlandicum was cited for urination problems in both study communities as well as in 
Whapmagoostui and in the literature survey (Marles et al., 2000). In the overall 
correspondence analysis, Juniperus communis is likewise linked to urination problems.  
Infection was a common ailment treated by the Cree, so it is not unexpected that we 
find a number of plants linked to this symptom (Arnason et al., 1981). Abies balsamea, 
Picea mariana and Larix laricina are common plants in the boreal forest and have known 
antibiotic properties, so it fits that they are associated both in our study and in the literature 
(Marles et al., 2000). In table 2.9, most of the species from our survey are represented and 
are highlighted in bold, although not always for the same symptoms. Other than differences 
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in the types of symptoms treated there are also many plants which are not mentioned in the 
four TAAM surveys. Many of these plants are not in our study area but are found in 
proximity to Cree communities in other parts of Canada. 
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Other Canadian aboriginal groups have treatments for these symptoms as well and it 
is often possible to recognize similarities. For instance the Dene of Western Canada treat 
diarrhea with Rhododendron groenlandicum, as was found in our study and in the literature 
(Marles et al., 2000). Larix laricina, is also used by this group to treat boils and by the 
Metis to treat infection. First Nations of the Maritime Provinces treat diarrhea using Prunus 
virginiana L., a plant not mentioned in our survey but which was recorded for the Cree 
(table 2.9) (Van Wart, 1948). Larix laricina, which is used by the Ojibway to treat 
headache, is also on record as a treatment for symptoms of diabetes by the Cree, 
specifically infection, blurred vision, abscesses and/or boils, arthritis/rheumatism and heart 
problems (Youngken, 1925). In this way the use of plants for other symptoms of diabetes 
by other groups serves to complement and help identify potential plants for further testing. 
Plants such as Larix laricina, capable of treating many of the problems in the diabetes 
spectrum at once, can be very interesting for future investigations.  
The newly identified plants Heracleum maximum and Thuja occidentalis are also 
found in the literature; however, the uses cited in the Waskaganish survey have not yet 
specifically been recorded for the Cree (see table 2.10). Several of the symptoms cited in 
the literature are, however manifestations of diabetes (headache, abscesses/toothache, 
arthritis/rheumatism, chest pain and diarrhea), which affirms the anti-diabetic potential of 
these plants. Further disease specific in vitro investigation is necessary but should be done 
cautiously, as these two plants contain toxins. Heraculeum maximum contains 
furanocoumarins that are triggered by ultraviolet light and Thuja occidentalis contains 
thujone, a known neurotoxin (Marles et al., 2000). It is likely that the traditional method of 
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preparing these remedies eliminates toxicity. For example the decoction of cedar in water 
helps to eliminate the hydrophobic toxin thujone (Marles et al., 2000).  
Table 2.10 Cree usage of Heracleum maximum and Thuja occidentalis in the literature and 
in TAAM surveys (Holmes, 1884; Marles et al., 2000; Marshall and Chiskamish, 1996; 
Marshall et al., 1989; Seigfried, 1994).  
Plant Literature TAAM survey 
  symptom organ Symptom Organ 
Heracleum maximum aches, headache, toothache, 
arthritis/rheumatism, colds, 
impetigo, scabies, painful 
limbs, worms in flesh 
root infections, 
urination problems 
Root 
Thuja occidentalis chest pain, congested chest, 
cough, cuts, diarrhea, 
diuretic, impetigo scabies, 
stomach problems 
leaves heart/chest pain, 
headache, 
back/kidney pain 
leaves 
 
2.5. Conclusion 
This ethnobotanical survey has furthered our understanding of plant use among the 
Cree of Eeyou Istchee and has allowed for more informed in vitro and in vivo investigation. 
Many related projects have been completed and are ongoing in tandem with the one 
represented here. One such caveat is an in vitro study of Picea mariana’s bioactivity in 
relation to high glucose stress in PC12-AC cells (a diabetic neuropathy model). This has 
emerged from the information found here that P. mariana is tied to symptoms related to 
diabetic nerve damage. These symptoms include slow healing infections and foot sores. 
Further phytochemical investigations involving Heracleum maximum and Thuja 
occidentalis, the newly identified plants, are also underway. The ethnobotanical data herein 
will help to determine the suitability of future bioassays.  
The similarities in pharmacopoeia found here will likely ease the transition of 
traditional medicines into modern facilities. Recommendations that can be made general 
and standardized will be easier to validate and will likely breed more confidence among 
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health care practitioners. It is however, important not to forget what makes each 
communities’ pharmacopoeia unique. Recommending plants that are not locally available 
or used are not necessarily culturally appropriate. For example we can now avoid 
recommending Rhododendron tomentosum ssp. subarticum despite its favourable rank in 
Waskaganish, Nemaska or Mistissini as this would not be in keeping with their respective 
pharmacopoeias. Recommendations involving a plant found in the given communities but 
for a purpose outside of the traditional use may also confer cultural inappropriateness.   
In reality it is up to the community members to decide what is “culturally 
appropriate” for their treatment. It may be enough that all treatments come from the Cree of 
Eeyou Istchee for their trusted use, or perhaps individuals will prefer to only use plants 
from their own local pharmacopeia. Focus groups which address these questions have been 
completed and their analysis is underway (Tabib, unpublished). With the information from 
both of these studies TAAM should be able to make recommendations to communities 
when positive results are obtained.  
The incorporation of traditional medicine should improve the health status of 
diabetes patients in Eeyou Istchee by having encouraged the community to participate in 
the development of their own personalized healthcare. It is anticipated that a better 
understanding and fulfilment of social and cultural needs will decrease the incidence of the 
disease and the severity of complications suffered. In discussion with community members, 
we are seeing that diabetes patients want to take charge of their health and that a new sense 
of confidence in old traditions is bourgeoning. We would like to acknowledge that this 
project was made possible due to the wisdom embodied by the elders and healers who have 
lead us throughout these investigations. As an elder once said “you (the scientists) are 
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paddling the canoe but we the elders are in the back steering and navigating the way”. It is 
with this motto for our collaboration that we continue these studies. 
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Growth Environment and Organ Specific Variation in Cytoprotective Antidiabetic 
Activities of Picea mariana: A Plant Used for Treatment of Diabetes Symptoms by the 
Cree of Eeyou Istchee (Quebec, Canada) 
 
Ashleigh D. Downing, Andrew Tang, Fida Ahmed, Cory S. Harris, Ammar Saleem, Pierre 
S. Haddad, Timothy Johns, Alain Cuerrier, John T. Arnason and Steffany A.L. Bennett 
 
Abstract 
The Cree of Eeyou Istchee, suffer from a high rate of diabetes and its complications partly 
due to the incompatibility of the western lifestyle and diabetes regimens with Cree culture. 
As part of a search for alternative medicine based on traditional practice and 
pharmacopoeia this project has evaluated the biological activity of alcohol extracts of 
needle, bark and cone one plant Picea mariana (Mill.) Britton, Sterns & Poggenb., in 
preventing glucose toxicity to PC12-AC cells in vitro (a diabetic neurophathy model). All 
extracts were well-tolerated in vitro exhibiting an LD50 of 25 μg/ml or higher.  Extracts 
were then tested for their ability to protect PC12 cells from hyperglycaemic challenge at 
physiologically relevant concentrations of 0.25, 0.5, 1.0 and 2.0 μg/ml.  Extracts from all 
organs tested exhibited a cytoprotective concentration-dependent response. Furthermore, 
organ-specific protection was habitat and growth environment dependent with plants grown 
either in bog or forest habitats in coastal or inland environments exhibiting different 
cytoprotective efficacies. These differences in activity correlated with total phenolic 
content but not antioxidant activity. Together, these results provide further understanding of 
the antidiabetic activity of Canadian boreal forest plants identified by the Cree of Eeyou 
Istchee healers at the cellular level. Their activity is relevant to diabetic peripheral 
neuropathic complications and shows that their properties can be optimized by harvesting 
in optimal growth environments. 
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3.1 Introduction 
In recent years, there has been increasing recognition of the deteriorating health 
status of Canadian First Nation peoples with respect to chronic diseases (Newbold, 1998; 
Tookenay, 1996). Among the chronic diseases afflicting these populations, diabetes has 
stood out as a literal epidemic (Health Canada, 1999; 2000; Young et al., 2000). Low levels 
of compliance due to treatment incompatibility has led to high levels of severe 
complications in these populations (Boston et al., 1997; Gittelsohn et al., 1995; Legaré, 
2004; Marbella et al., 1998; Young et al., 2000). The proposed solution, as part of the 
CIHR Team in Aboriginal Antidiabetic Medicines (TAAM), is to make traditional 
treatment options readily available alongside conventional treatment (Letendre, 2002; 
Marbella et al., 1998). To accomplish this goal, semi-structured ethnobotanical surveys 
have been conducted in Misstisini, Whapmagoostui (Fraser et al., 2007; Leduc et al., 2006), 
Waskaganish and Nemaska (Chapter 2).  
Picea mariana (Mill.) Britton, Sterns & Poggenb., commonly known as black 
spruce, has emerged in these surveys as a top ranking plant. Specifically, it is a treatment 
for symptoms related to diabetic neuropathy (Downing in preparation;Fraser et al.2007; 
Leduc et al, 2006). To date, only antidiabetic activities of a cone extract have been 
investigated by the TAAM team. The extract showed high antioxidant activity, insulin 
sensitizing and glitazone-like effects, as well as protection of PC12 cells, a model of 
peripheral neuronal precursors from high glucose insult (Fraser et al., 2007; Spoor et al., 
2006). Given these data and that extracts from needles of Picea glauca (Moench) Voss (a 
closely related species) also protect PC12 cells from hyperglycemic challenge, we 
compared the cytoprotective efficacy of extracts prepared from three different organs 
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(needle, bark and cone) of P. mariana collected at different geographical locations and 
ecological conditions.  Our primary goal was to establish whether cytoprotective activity 
was dependent upon habitat and growth environment and to elucidate what the ideal 
collection conditions might be for this plant. Here we describe how cytoprotective and 
mitogenic activities differ between extracts sampled from coastal and inland populations 
(Waskaganish to Mistissini) in areas where bog (low land) met forest (high land). Nine 
Eeyou Istchee communities across a varied northern Quebec landscape may incorporate the 
use of traditional pharmacopeia into clinics. The evaluation of local harvesting is essential 
to determine whether plant organs will yield similar benefits under different growing 
conditions. The development of this research question has come directly from the elders of 
Eeyou Istchee who emphasize the importance of plant selection and regional variation. 
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3.2 Materials and Methods 
3.2.1 Plant Material 
P. mariana organs (needle, bark and cone) were harvested in proximity to the Cree 
communities of Waskaganish, Nemaska and Mistissini located within the 50° and 51° N 
latitudes (Quebec, Canada). Twenty one populations were selected (Fig 3.1). Plants were 
harvested at the boundaries of high land (forest) and low land (bog) to enable collection 
from two distinct habitats (bog or forest) within the same geographical growth environment 
(measured as proximity to the James Bay coast). Growth environment was considered 
coastal if it was < 50km from the coast and inland if further. To ensure that habitats were 
distinct, bog stands were defined as trees growing in > 30 cm sphagnum moss. Forests were 
defined as having trees growing in organic soil with < 20 cm sphagnum moss ground cover. 
Separate populations had to be at least 5 km apart and in most cases were much further in 
order to sample across all three communities. Needles and bark were harvested from ten 
trees within a 50 m radius for each habitat. Cones were collected from the same trees when 
available. However they were often unreachable or not present. All bulk materials were air 
dried upon collection and dried to completion in a plant drier at 40ºC prior to shipment. The 
dried samples were extracted at the University of Ottawa. Voucher specimens were 
deposited at the Marie-Victorin, Université de Montréal, Herbarium (MT)(appendix VIIII).   
3.2.2 Extract preparation  
Twenty populations of needles were extracted. Pooled samples were made by 
weighing out 0.2 g of material from each tree (10x) resulting in a total of 2 g per location. 
The 2 g sample was placed in a magic bullet blender (Homeland Housewares) along with 
20 ml of 80% ethanol (10 ml/g material) and collected in 50 ml falcon tubes (Fisher). After 
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blending, the sample was sonicated for 20 min and the first extraction mixture was stored at 
4ºC for one week. The ethanol extract was centrifuged for 15 min at 1811 g and the liquid 
supernatant was removed by pipette and stored at 4ºC. Ten ml of fresh 80% ethanol was 
added to the pellet, sonicated and stored at 4°C. The second supernatant was then removed 
and added in the same fashion as the first. Alcohol was then removed from the pooled 
supernatant using a Labconco Centrivap at 40ºC for 72 h. The alcohol-free extract was 
lyophilized using a freeze drier (Edwards Pirani 501) for 72 h. The result was a dry stable 
extract that was homogenized and stored in a freezer at -20ºC. Nine of the twenty 
populations were included for the analysis of bark extracts. It was necessary in the case of 
bark and cone to grind samples in a Willey mill (2 mm mesh) tree by tree before evenly 
pooling the populations. As before 2 g of the pooled, sample was processed using the same 
protocol as for the needles. In the case of cones, however, only five extracts were prepared 
by pooling 4 trees per population due to a lack of material. A total of sixty four different 
extracts were prepared (20 needle bog, 20 needle forest, 9 bark bog, 9 bark forest and 6 
cone bog = 64 ).   
Extraction of needles for the isolation of compounds was completed using 1 kg 
mixed bog and forest black spruce needles. Needles were ground using a Willey mill and a 
2 mm mesh. Five liters of 80 % ethanol was added to the needles and left to stir for 24 h. 
The alcohol was then collected using vacuum-filtration through Whitman paper no 1. An 
additional 5 L of 80% ethanol was added to the needle filtrate and left to stir for 24 h. 
Supernatant was collected as before and combined with the first aliquot. Alcohol was 
removed using a rotary evaporator and samples were then lyophilized. The dry extract was 
homogenized and stored at 4ºC. 
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3.2.3 Cell Culture and Bioactivity Assays 
Cells of the clonal derivate of the PC12 rat pheochromocytoma cell line (American 
Type Culture Collection), PC12-AC (Brewer et al., 2002), were maintained in 10 cm dishes 
with 10 ml complete media (RPMI, 10% horse serum, 5% new born calf serum) at 37ºC 
with 5% atmospheric CO2. Complete media provided a normoglucose environment (11 mM 
glucose). Bioactivity was assessed as previously described (Harris et al., 2008; Harris et al., 
2007). To elicit glucose toxicity (hyperglycemia), complete medium was replaced with this 
same serum-free media supplemented with 150 mM glucose and 0.025% BSA. Following 
96 h (hyperglycemia assays) of treatment, WST (Roche Diagnostics) was added to each 
well and incubated for 60 minutes before spectrophotometric analysis at 420 nm (formazan) 
and 620 nm (reference). Cultures were compared to cell-free treatment media incubated for 
the same period. Cell number per well was calculated from standard curves derived from 
wells containing known cell densities. Standardization allowed data to be compared across 
replicates. For LD50 assessments, each compound was tested at eight different 
concentrations in quintuplicate over two separate experiments (n=15 per concentration).  
For hyperglycemia assays, each compound was tested at four different concentrations in a 
minimum of triplicate measures (n=3-6). Data from control cultures were combined across 
plates (n=54). Percent viability was calculated as follows: % viability = cell number(treatment 
well) / mean cell number(control). Assigned bioactivities (cytotoxic, cytoprotective, or 
mitogenic) based on this screen were validated by direct assessment of viable cell number 
using Trypan Blue hemocytometer counts. 
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3.2.4 DPPH Antioxidant Assay 
Extracts were tested for their radical scavenging activity using the 1,1-diphenyl-2-
picryl-hydrazyle radical (DPPH)  test as in Owen and Johns, 2002. Ascorbic acid (AA) was 
used as a control to generate a standard curve for the calculation of its IC50:the 
concentration where 50% of the DPPH radical is quenched by AA. The following Least 
squares regression equation was used [    
 
 02
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yyxx
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the line of best fit for the IC50 calculation where y=absorbance at 517nm and x= 
concentration in ppm.This method is employed over the traditional method of discerning 
the linear portion of the line visually and we believe it to be a more accurate method of 
extrapolation.Pure catechin and epicatechin compound was used as positive controls for 
comparison to crude plant extract samples. Extracts identified as having bioactivity in both 
screening paradigms and following direct validation were tested to determine whether 
antioxidant activity correlated with cytoprotection or mitogenicity in hyperglycemic media.  
Three independent assays were run with samples tested in duplicate.  
3.2.5 Total Phenolics Test 
The Folin-Ciocalteau method was used as described by Singleton and Rossi (1965), 
and later modified by Harris et al. (2008). A standard curve was constructed using dilutions 
of quercetin (Sigma Aldrich Co) at concentrations of 1.0, 0.75, 0.5, 0.25, 0.10, and 0.05 
mg/ml. Eight hundred micro liters of Folin reagent was added to 160ul of sample with 
540ul 7.5% NaHCO3 and stored in the dark for 2 h. Absorbance was recorded at 725 nm 
using a spectrophotometer (Molecular Devices SpectraMax 5). Fifteen milligrams of crude 
extract was re-solubilized in 80% ethanol at 10 mg/ml inside 1.5 ml centrifuge tubes. The 
56


samples were then vortexed until totally dissolved and sonicated for 15 min. These extracts 
were dyed using the same procedure and the concentration determined using the standard 
curve. 
3.2.6 Fractionation and Isolation of Compounds 
Pooled needle extracts (100 g) containing bog and forest needles were adsorbed on 
200g of silica gel (200-300 nm) in the presence of 100% methanol. Absorbed extract was 
left to air dry for 2 days before being placed on the top of a column (60 cm x 10 cm). In 
order to complete the fractionation process, hexane, ethyl acetate and methanol were used 
as mobile phases. The first phase run was 2 L of 100% hexane and progressed to 2 L of 
90:10 (hexane:ethyl acetate). Each subsequent addition reduced hexane by 10% until 100% 
ethyl acetate was attained. The same procedure was followed with 100% methanol. 
Fractions were collected in 200 ml aliquots. Solvent from each fraction was evaporated and 
remnants were separated using silicon plate thin layer chromatography.  
3.2.7 HPLC  
Samples were prepared by dissolving 40 mg of crude extract in 1 ml of methanol 
(Sigma Aldrich). A standard of 600 l of resveratrol (1 mg/ml) (Sigma, St Louis, MO) was 
added to 500 l of extract to make a total volume of 1100 μl. The mixture was filtered 
through a 0.2 m PTFE nylon membrane filter (Chromatographic Specialities Inc., 
Brockville, ON, Canada) and sonicated for 5 min before injection. 
Needle, bark and cone extracts were characterized by HPLC-DAD analysis using a 
novel method for the identification of phenolic metabolites. Analyses were performed on an 
Agilent 1100 HPLC-DAD (Palo Alto, CA, USA) comprising an autosampler, a quaternary 
pump, a column thermostat, and a photodiode array detector (DAD). Separations were 
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performed on an YMC ODS-AM column (100 ×2 mm i.d.; 3 m particle size) (Waters, 
Mississauga, Canada) at 55ºC and a flow rate of 0.3 mL/min. The elution conditions 
consisted of HPLC grade water (Sigma) in solvent A and acetyl nitrile (Sigma) as solvent B 
with initial conditions starting at 85:15 (%A:%B) at the elapsed time of 0 min, 35:65 at 15 
min, 0:100 at 15.1 min and held until 20 min. The injection volume was 1 L of extract 
individually injected through a 100 L loop of the autosampler. The chromatographic 
separation was monitored at 280 nm by DAD. The internal standard, resveratrol, was tested 
for comparison to ensure there was no interference between it and the eluting compounds. 
Pungenin’s identity was confirmed in needles using this HPLC method and in comparing 
values to the literature. The isolated pungenin was used as an external standard for HPLC 
analysis of crude needle extract. 
3.3 Results 
3.3.1 Bioactivity 
Upon extraction, 18%, 25% and 30% of dried needles, bark and cone were 
sequestered. For each milligram of that extract, 146.5+4.2 μg (needles), 270.3+13.9 μg 
(bark) and 398.7+48.8 l μg (cone) were phenolic compounds. Each extract was screened at 
0.25-2 μg/ml for capacity to alter glucotoxicity in vitro (Appendix V, VI and VII, Tables 
3.1-3.3). Glucotoxicity reduced the number of viable cells to 56.8% that of normoglucose 
controls (Appendix v, vi, vii, C vs. HG). Samples were attributed biologically active if at 
least two or more concentrations elicited a statistically significant change in viable cell 
number. Compounds that increased viable cell number to values significantly higher than 
the normoglucose controls (> 100%) were considered mitogenic. Compounds that 
significantly protected cells from high glucose toxicity (56.8%) without exceeding 
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normoglucose viability values were considered cytoprotective; compounds that enhanced 
glucotoxicity at any concentration were considered cytotoxic. Maximal test concentrations 
were at least one log concentration below their LD50 in normoglucose media (data not 
shown).  
59


Table 3.1 Bioactivity of Picea marianna needle extracts in hyperglycemic media. 
Extract IDa Bioactivity in  
hyperglycemic mediab 
1FN Cytoprotective 
1BN None 
2FN None 
2BN None 
3FN None 
3BN None 
4FN None 
4BN None 
5FN None 
5BN None 
6FN Cytoprotective 
6BN Cytoprotective 
7FN None 
7BN Cytoprotective 
8FN Mitogenic 
8BN Mitogenic 
9FN None 
9BN Cytoprotective 
10FN Cytoprotective 
10BN None 
11FN None 
11BN None 
13FN None 
13BN None 
14FN None 
14BN None 
15FN None 
15BN None 
16FN Cytoprotective 
16BN None 
17FN Cytoprotective 
17BN Cytoprotective 
18FN Cytoprotective 
18BN Cytoprotective 
19FN None 
19BN Cytoprotective 
20FN None 
20BN None 
21FN Cytoprotective 
21BN None 
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aThe extract ID code defines the growth environment (Area#1-21, Fig 3.1.), habitat (B, Bog 
or F, forest) and organ (N, needle).  For example, 1FN is an extract prepared from needles 
collected in a forest habitat at location #1. 
bBioactivity was classified comparing a 96 h treatment in hyperglycemic (150 mM) serum-
free media. Viable cell number following extract treatment was established using the WST 
assay compared to standard curves of known cell number. Vehicle control was 0.1% 
DMSO. Compounds that at two or more concentrations (a) increased viable cell number to 
values significantly higher than the normoglucose controls (> 100%) were classified as 
mitogenic, (b) significantly protected cells from high glucose toxicity without apparent 
mitogenic activity were classified as cytoprotective, or (c) enhanced glucotoxicity were 
classified as cytotoxic.  Statistics were ANOVA, post-hoc Tukey tested vs. vehicle-treated 
cultures in normo- or high glucose media. All concentration-response data and statistical 
analyses are presented in Appendices v, vi and vii. 
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Table 3.2 Bioactivity of Picea marianna bark extracts in hyperglycemic media 
 
Extract IDa Bioactivity in  hyperglycemic mediab 
1FB Mitogenic 
1BB Mitogenic 
2FB Cytoprotective 
2BB Cytoprotective 
3FB Cytoprotective 
3BB Cytoprotective 
4FB Cytoprotective 
4BB Cytoprotective 
5FB None 
5BB None 
6FB Cytoprotective/Mitogenic 
6BB Cytoprotective/Mitogenic 
7FB Cytoprotective 
7BB Cytoprotective 
11FB None 
11BB Cytoprotective 
14FB None 
14BB None 
 
aThe extract ID code defines the growth environment (Area#1-21, Fig 3.1.), habitat (B, Bog 
or F, forest) and organ (B, bark).  For example, 1FB is an extract prepared from bark 
collected in a forest habitat at location #1. 
bBioactivity was classified using a 96 h treatment in hyperglycemic (150 mM) serum-free 
media.  Viable cell number following extract treatment was established using the WST 
assay compared to standard curves of known cell number.  Vehicle control was 0.1% 
DMSO.  Compounds that at two or more concentrations (a) increased viable cell number to 
values significantly higher than the normoglucose controls (> 100%) were classified as 
mitogenic, (b) significantly protected cells from high glucose toxicity without apparent 
mitogenic activity were classified as cytoprotective, or (c) enhanced glucotoxicity were 
classified as cytotoxic. Samples classified with dual bioactivities (ie. 
Cytoprotective/Mitogenic) are possible when two concentrations satisfy our definition of 
one bioactivity (ie. Cytoprotective) and two other concentrations from the same sample are 
in another category (ie. Mitogenic). Statistics were ANOVA, post-hoc Tukey tested vs. 
vehicle-treated cultures in normo- or high glucose media.  All concentration-response data 
and statistical analyses are presented in Appendices v, vi and vii. 
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Table 3.3 Bioactivity of Picea marianna cone extracts in hyperglycemic media. 
Extract IDa Bioactivity in  
hyperglycemic mediab 
3BC Cytoprotective 
7BC Cytoprotective 
11BC Mitogenic 
12BC Mitogenic 
14BC None 
15BC None 
 
aThe extract ID code defines the growth environment (Area#1-21, Fig 3.1.), habitat (B, Bog 
or F, forest) and organ (C, cone).  For example, 1BC is an extract prepared from cones 
collected in a bog habitat at location #1. 
bBioactivity was classified comparing a 96 h treatment in hyperglycemic (150 mM) serum-
free media. Viable cell number following extract treatment was established using the WST 
assay compared to standard curves of known cell number.  Vehicle control was 0.1% 
DMSO.  Compounds that at two or more concentrations (a) increased viable cell number to 
values significantly higher than the normoglucose controls (> 100%) were classified as 
mitogenic, (b) significantly protected cells from high glucose toxicity without apparent 
mitogenic activity were classified as cytoprotective, or (c) enhanced glucotoxicity were 
classified as cytotoxic.  Statistics were ANOVA, post-hoc Tukey tested vs. vehicle-treated 
cultures in normo- or high glucose media.  All concentration-response data and statistical 
analyses are presented in Appendices v, vi and vii. 
We found that 50% of all organ extracts improved viability of PC12 cultures under 
hyperglycemic conditions. Moreover, all extracts were well-tolerated in that none of them 
extracts enhanced glucose cytotoxicity. We identified twenty-four cytoprotective (38% of 
total) and seven mitogenic (9% of total) extracts. Two extracts (3% of total) exhibited both 
cytoprotective and mitogenic activities dependent upon the concentration tested (Table 3.1, 
3.3, Appendix v, vi, vii). When comparing the overall bioactivity of extracts prepared from 
needle, bark and cone collected at all regions and habitats, we found that protective effects 
were maximal at the lowest concentrations tested in all cases and were not organ-specific 
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with the exception that bark and cone were more effective mitogens in high glucose media 
than needle extracts (Tables 3.1-3.3, Appendix v, vi, vii, Fig 3.2).  
 
Figure 3.2 Comparison of cytoprotective and mitogenic activities of P. mariana needle (), 
bark () and cone () extracts. MANOVA analysis was used to average all extracts based 
on their organ type and concentration. Significant cytoprotection (*) or mitogenic activity 
(#) was afforded when Dunnett post hoc tests were p0.05 as compared to the 
normoglucose (C)and high glucose (HG)controls. All organs showed significant protection 
at all concentrations except cone at 2 ug/ml (needle n= 120, bark n= 60, cone n=18). 
3.3.2 Regional Variation 
A primary concern of the TAAM team is to provide laboratory data assessing the 
importance of plant selection and regional variation emphasized by the elders and healer of 
the Eeyou Istchee in their traditional preparations. Their insights are crucial to ensuring that 
plant usage will yield similar benefits in all communities. We found that fifty percent of P. 
mariana needle, bark, and cone extracts (32 extracts) did not exhibit significant biological 
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activity in our screening paradigm. To test whether extract efficacy depended upon the 
growth habitat where the plant had been harvested, we compared efficacy of needle and 
bark extracts collected in bog and forest habitats. Cone extracts were not included in this 
analysis as we were only able to collect cones from bog sites. 
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Figure 3.3 Comparison of cytoprotective and mitogenic activities by growth environment. 
MANOVA analysis was used to determine the mean viability with respect to habitat 
(forest/ bog), growth environment (coastal/inland), organ type (Needle = , Bark = ) and 
concentration (0.25, 0.50, 1.00, 2.00ug/ml) interactions. Significant protection (*) or 
mitogenic activity (#) was identified by Dunnett post hoc tests (p0.05) by comparison to 
the (C) normoglucose or (HG) high glucose controls respectively. The same p value was 
used to denote a significant difference between needle and bark (+) at specified 
concentrations. (A) Comparison of bark and needle extract protection in coastal forest 
environments (bark n= 12 needle n= 12). (B) Comparison of bark and needle extract 
protection in coastal bog environments (bark n= 12, needle n= 12). (C) Comparison of bark 
and needle extract protection in inland forest environments (bark n= 18, needle n= 51). (D) 
Comparison of bark and needle extract protection in inland bog environments (bark n= 18, 
needle n= 45). 
 
We did not detect any statistically significant differences between the bioactivites of 
needle and bark extracts grown in different habitats (data not shown). To test whether 
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growth environment and habitat interacted to produce organs with different bioactivities, 
samples collected in different growth habitats, were grouped into coastal or inland  
environments (Fig 3.1). This analysis revealed a statistically significant interaction between 
growth environment, habitat, and organ bioactivity (Fig 3.3). Extracts prepared from bark 
collected in coastal environments showed cytoprotection where needles extracts did not 
(Fig 3.3 A & C).  Moreover, in coastal-derived extracts, activity was maximal (and 
concentration-dependent) at low concentrations in extracts prepared from bark collected in 
a forest habitat (Fig 3.3 A) and at high concentrations in extracts prepared from bark 
collected in a bog habitat (Fig 3.3 B). At their highest percent viability extracts were even 
mitogenic. This interaction was organ-specific. Neither growth environment nor habitat 
altered the cytoprotective efficacy of needle extracts (Fig 3.3 A-D).   
3.3.3 Total Phenolics and Antioxidant Activity 
These data suggest that the quantity of biologically active compounds are 
responsible for organ-specific, habitat dependant cytoprotective bioactivities of the extracts. 
It has previously been suggested by Spoor et al. (2006), that antioxidant activity is 
responsible for antidiabetic activities in P. mariana cone extracts. To further explore this 
hypothesis, we measured total phenolic content in the needle, bark and cone extracts (Fig 
3.4) and correlated this content with the antioxidant activity of selected extracts using the 
Folin-Ciocalteau total phenolics method and DPPH antioxidant tests employed in previous 
TAAM studies (Spoor et al., 2006).   
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Figure 3.4 Total phenolic content in terms of quercetin equivalents, of P. mariana needle, 
bark and cone extracts. Needle, bark and cone phenolic content was found to be 
significantly different from each other at p0.05 ((*) = significantly different from needle; 
(#) = significantly different from bark; (%) = significantly different from cone). Cone had 
the highest phenolic content with 398.68 (SE = 48.77, n = 5), followed by bark at 244.08 
(SE = 14.51, n = 18) and needle with 146.34μg/milligram extract (SE = 3.78, n = 40). 
 
 
Figure 3.5 Regression analysis of total phenolic content with respect to antioxidant activity. 
Total phenolic content is measured in terms of quercetin equivalents and antioxidant 
activity is calculated with respect to the ascorbic acid standard curve. The trend shows that 
as phenolic content increases the amount of plant extract (EC50 in ppm) necessary to reach 
the IC50 of ascorbic acid decreases and therefore, antioxidant activity increases with 
increasing phenolic content (r2=0.63, p0.05, n = 14). The data passed a normality test in 
order to ensure that it follows a normal distribution.   
 

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We found that the combined phenolic content was highest in cone extracts and 
lowest in needle (Fig 3.4). DPPH antioxidant assays were completed on fourteen selected 
extracts and plotted with respect to phenolic content (Fig 3.5). A significant correlation 
between antioxidant activity and total phenolic content was detected (r2=0.63, p<0.05, Fig 
3.5) Total phenolic content positively correlated with bioactivity (r2=0.30, p=0.05, Fig 3.6, 
Tables 3.1-3.3). Antioxidant activity however, was not correlated with bioactivity 
(r2=0.046, p=0.460, Fig 3.7). Taken together, these results suggest that, while the phenolic 
content of organ extracts prepared from plants harvested in different habitats and growth 
environments likely underlies bioactivity, the oxyradical scavenging capacity of these 
phenolics is not the primary mechanisms of action. 
 
Figure 3.6 Regression analysis of total phenolic content with respect to PC12-AC 
bioactivity in high glucose media. The trend shows that as phenolic content increases the 
percent viability increases (p0.05, n=13).  
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. 
Figure 3.7 Regression analysis of antioxidant activity with respect to PC12-AC bioactivity 
in high glucose media. Antioxidant activity is measured with respect to ascorbic acid and 
bioactivity is represented as percent viability with respect to normoglucose control. We do 
not see any kind of a trend here so antioxidant activity is not likely the main mechanism of 
protection (p = 0.89, n=13). 
 
3.4 Discussion  
There is a paucity of strategies effective in managing chronic pain, infection, 
paralysis, and loss of sensation association with peripheral diabetic neuropathy (Kuzmina et 
al., 2008; Legaré, 2004). Based on our ethnobotanical studies, we have observed that 
preparations from various organs of P. mariana are used to treat slow healing infections, 
sores and numbness (particularly of the extremities), all symptoms related to diabetic 
neuropathy. We demonstrate for the first time that P. mariana needles and bark are 
effective protectors of peripheral neuronal precursor survival when exposed to 
hyperglycemic conditions. We confirm the protection of cones as was first demonstrated by 
Spoor et al. (2006). We have also shown that harvest location can impact the antidiabetic 
bioactivities of P. mariana, particularly for bark extracts, which tended to be more effective 
when obtained from inland forest populations than from to coastal and inland bog 
populations. In general the strength of the observed activity of needle, bark and cone is 
correlated with the total phenolic concentration of the extracts. The one notable exception 
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was a cone extract that was suspected to have caused oxidation, a negative response, in 
PC12-AC cells. The presence of too many antioxidants can actually be harmful, resulting in 
oxidation and therefore a decrease in cell survival. This is something that was observed in 
preliminary DPPH tests at higher extract concentrations (Diouf et al., 2009).  
These in vitro findings validate the importance of P. mariana’s role as part of the 
Cree pharmacopoeia and underline the importance of plant selection and extract strength. In 
a review of Canadian aboriginal plant use, Marles et al. (2000), has reported that this plant 
is used by the Cree to treat heart problems, high blood pressure, diarrhea, chicken pox, ear 
and skin infections, rashes, scabies, shortness of breath, sore eyes, sore mouth, sore 
stomach and sore breasts from breastfeeding. Here we have added, to TAAMs 
ethnobotanical and in vitro findings (Fraser et al., 2007; Leduc et al., 2006; Martineau et 
al., 2010; Spoor et al., 2006) by contributing positive evidence that boreal plants from the 
Cree pharmacopoeia are capable of treating diabetes symptoms. Specifically we have 
shown at the cellular level, that this traditional medicine may be effective in the treatment 
of a “new” disease afflicting First Nation peoples, namely the potential to manage diabetic 
peripheral symptoms by protecting peripheral neurons and their precursors from 
hyperglycemic insult. 
These results are similar to those found in Harris et al., (2008) for P. glauca, except 
that all P. mariana organs showed protection. In contrast to Harris et al. (2008) findings, P. 
mariana needles were generally the lowest protector against diabetic insult. One factor that 
should be re-examined in the case of P. glauca is concentration range. It may be necessary 
to test bark and cone at much lower concentrations than 10 μg/ml. This is recommended 
because our graphs often showed a decreasing dose response from the lowest concentration 
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to the highest (figure 3.2). Conversely, given strong correlations in both studies with total 
phenolic content, these data could also suggest species differences in the phenolic 
constituents of the different organs that underlie the cytoprotective and mitogenic 
bioactivities. This is a good argument for the comprehensive fractionation based assays of 
organs collected at different locations and under different growth habitats in order to 
identify active components.   
To this end, we have initiated preliminary HPLC fractionation and isolation of 
compounds to begin the required bioassay-guided fractionation necessary to test this 
hypothesis. We have found pungenin and several pungenin-like compounds to be the main 
constituents of needle extracts, yet absent from bark and cone extracts (unpublished data; 
see also Harris et al., (2008) for similar results with extracts from P. glauca). Pungenin also 
known as the glycoside of 3,4 dihydroxyacetophenone was first isolated and identified from 
the leafy branches of  Picea pungens Engelm or Colorado spruce (Neish, 1957). It was later 
identified in Picea glauca as well and found to be seasonally variable, having higher 
quantities in the winter than in the summer (Neish, 1958). More recently pugenin has been 
identified in Ficus septica Burm f. a plant often employed in folk medicine of the Western 
Pacific, thought to have anticancer and anti-inflammatory potential (Lansky et al., 2008; 
Ueda et al., 2009). This is interesting because inflammation is a symptom associated with 
obesity related diabetes (Wellen and Hotamisligil, 2006). Anti-inflammatory activities have 
already been shown for Picea mariana by Diouf et al. (2009) so it would be interesting to 
see if pungenin is responsible for some of this activity. This has particular relevance to us 
as it is also highly soluble in hot water and is likely easily decocted, a method often 
employed by traditional practitioners (Neish, 1957).   
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Primary fractionation of P. mariana bark samples did not yield any pure compounds 
but close examination of the chromatographs indicated that these extracts are likely 
enriched in stilbenes. Stilbenes are a group of biologically active molecules previously 
identified in Abies, Picea, Pinus, Juniperus, Rheum and Morus species (Chrzascik, 2009). 
These compounds have been shown to, improve blood circulation, lower cholesterol, have 
estrogenic effects, stimulate protein synthesis, have fungicidal activities, stimulate bone and 
cartilage development, have anti-cancer activities and are strong antioxidants (Chrzascik, 
2009). Chromatographs suggest that there are similarities between the stilbenes found in 
Picea mariana and that of the most widely studied stilbene resveratrol, a known 
cytoprotector found in red wine (Fremont, 2000). For cones, chromatograms suggest high 
concentrations of tannins and this will require further mass spectrometry analysis for 
isolation and identification. While still preliminary, this approach can identify the bioactive 
compounds that underlie species differences as well as reflect the observed growth 
environment and habitat impact upon extract efficiency. 
Our data are also consistent with the commercial application of Pinaceae family 
members as sources of antidiabetic pharmacetucials. Pycnogenol® is made from the bark of 
Pinus pinaster Aiton and has been purported to exhibit antidiabetic activity. In clinical 
trials with diabetic patients, Pycnogenol® has shown an ability to reduce blood glucose 
levels, cardiovascular risk factors and, more interestingly for this study, to halt the 
progression of and even improve retinopathy (Liu et al., 2004; Spadea and Balestrazzi, 
2001; Zibadi et al., 2008).  As P. mariana and P. pinaster are in the same family we would 
expect their phytochemistry to be similar and perhaps have comparable bioactivities. Diouf 
et al., (2009) have indeed shown the phyochemistry of P. pinaster and P. mariana to be 
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comparable. Morevoer, it is the proanthocyanidin rich fractions that appear to be of interest, 
as these biomolecules make up the bulk of the Pycnogenol® supplement. Further, P. 
mariana extracts have been shown not only to be good antioxidants, as demonstrated here, 
but also confer anti-inflammatory protection (Diouf et al., 2009; Walshe-Roussel et al., 
2009), which may provide further avenues for diabetes treatment. For example, TNF-, an 
inflammatory cytokine, which is overproduced in the adipose tissues of obese individuals 
and in the presence of high levels of free fatty acids is associated with insulin resistance 
(Shoelson et al., 2006; Wellen and Hotamisligil, 2006). In this case TNF- inhibits insulin 
action by blocking the downstream signaling from the insulin receptor. In chapter one we 
discussed how this same cytokine is simulated by the production of ROS (Tiwari and Rao, 
2002). Plants which could prevent the chronic low level inflammatory responses that are 
associated with obesity, would make excellent candidates for diabetes treatment by 
preventing or alleviating insulin resistance and this may be the case for Picea mariana 
(Walshe-Roussel et al., 2009; Wellen and Hotamisligil, 2006).   
 We further show that extract efficacy depends upon careful selection of plant organs 
depending upon growth environment and habitat as indicated by the Cree elders and healers 
of Eeyou Istchee. This is an important finding as it supports the efforts of traditional 
practitioners in ensuring equivalent benefits across communities. Variation in activity by 
growth environment was observable mainly for bark. In this case, we recommend inland 
populations or, if harvesting in proximity to the coast, to choose forest sites instead of bog 
sites. Conveniently, this is easier ground to navigate and a less fragile habitat. However, if a 
bog is the only site available for harvesting, it may be possible to achieve the same level of 
protection in coastal sites, for example, by simply using more plant material per treatment 
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preparation. In the case of needles, neither growth environment nor habitat altered the 
cytoprotective efficacy of extracts, so no special recommendations are warranted. A lack of 
specificity should allow collectors to avoid over harvesting in one area and therefore, 
decreases the possibility of harmful environmental impacts.  
3.5 Conclusion 
P. mariana is an effective protector of peripheral neuronal precursor survival when 
cells are subjected to high glucose conditions. All organs tested in this diabetic neuropathy 
model, that is needles, bark and cone, proved to be efficacious. As all organ parts are 
protective and the boreal forest of Canada is highly populated by this tree species, we 
believe P. mariana is an excellent candidate for a renewable source of medicine. Further in 
vitro investigations are necessary to elucidate the underlying mechanisms of action and 
phenolic variation. In vivo, tests in diabetes specific animal models are also needed to 
confirm that bioactivity remains upon ingestion. Of course the successful application of this 
study’s findings will also depend on the continuation of an already interdependent 
relationship developed by the TAAM team, health care professionals and the Eeyou Istchee 
communities. As the bonds we have built are strong, we are confident that not only P. 
mariana but many of the plants from the Cree pharmacopeia will become part of a new 
holistic form of diabetes treatment, culturally acceptable to the Cree of Eeyou Istchee and 
supported by traditional practice and evidence-based inquiry.   
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Chapter 4 – Conclusion 
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 Here we have contributed to the recording of medicinal plant uses for two Cree 
communities. We have identified two new plants, Heraculeum maximum and Thuja 
occidentalis, for the treatment of diabetes symptoms and have provided new avenues for in 
vitro analysis. The relationships between community pharmacopeias have been examined, 
which has increased our understanding of shared knowledge, while giving us an 
appreciation for what makes them unique. In Waskaganish, Thuja occidentalis, Heracleum 
maximum and Sarracenia purpurea were used exclusively in comparison to Nemaska, 
where the use of Kalmia angustifolia was distinct. However, what makes these two 
communities different from each other was what made them similar with reference to the 
other communities. For example, both Sarracenia purpurea and Kalmia angustifolia had 
been identified as medicinal plants in Mistissini (Leduc et al., 2006). With respect to plant 
importance as measured by SIV ranking and evaluated by the Spearman rank test, ranking 
of common plants was similar in all community comparisons when Picea glauca was not 
considered. This plant likely represents a difference of importance based on abundance.  It 
would be interesting to go deeper in elucidating why plants are similarly ranked or 
otherwise using floristic and geographical data analysis. Plant use with respect to symptoms 
and citation number (i.e. Podani algorithm) was also similar for all community comparisons 
except Nemaska/Whapmagoostui. Differences here were likely magnified due to the small 
sample size and therefore low number of mentions of fewer plants in Nemaska. For this 
reason we conclude that the Spearman rank test and Podani algorithm has provided positive 
evidence for our H1 hypothesis.  Mantel analysis provided contradictory results to the 
Podani analysis, only showing a correlation between Nemaska/Waskaganish. It is likely 
that this method was not well suited for this analysis but we cannot ignore these 
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results(Dutilleul et al., 2000). It would be useful to either try using squared Euclidean 
distance in the Mantel test as described by Dutilleul et al. (2000) or to find some other 
means of comparing presence or absence of use for these communities in order to confirm 
our suspicions. The development of a method which takes into account how many 
community members have been consulted and somehow weighs each mention accordingly 
may be helpful. In this respect, this study has served to highlight the utility of some 
statistical methods and the limitations of others for the field of ethnobotany.  
Further to this, symptom-species correlations have been examined for the purpose 
of in vitro investigation. These correlations have given us the opportunity to examine 
relationships for the two new communities and for all four pooled pharmacopeias. Overall 
we can say that there are many plants which are associated with several symptoms of 
diabetes and this is demonstrated by the clumping of species and symptoms in the overall 
correspondence analysis (figure 2.7, appendix IV). Specifically strong relationships were 
observed in Waskaganish correspondence analysis for Alnus incana ssp rugosa (abscesses 
and boils), Populus balsamifera (abscesses and boils), Thuja occidentalis (heart/chest pain) 
and Abies balsamea (infections). Likewise in Nemaska Larix laricina had strong ties to the 
infection symptom. In both of these communities and in the pooled analysis Abies 
balsamea was well linked to vision problems.  
Despite the value of these analyses, it is our position that all mentions of plant use 
be taken into account, as much information has been lost with the passing on of the 
previous generation in these communities. Therefore a lack of citation may not necessarily 
mean a lack of importance or efficacy. Although we have broached the topic of symptom-
species relationships statistically, the specific mentions of preparation, animal uses and 
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their related symptoms have been left out. This information is considered either sacred or 
the types of uses mentioned were outside the scope of this report and have therefore been 
omitted. In the future we hope to not only put the aforementioned findings to use through 
the incorporation of traditional medicine but also to give all the knowledge, not just that 
represented here, back to the community in a comprehensive way. As a contribution to the 
field of ethnobotany this study is representative of work done entirely in cooperation with 
the community and should serve as an example for future ethnobotanical investigations.  
In the second half of the report we have validated the utility of an ethnobotanical 
approach in identifying plants for the treatment of type II diabetes (Oubré et al., 1997). We 
demonstrate that Picea mariana’s high SIV ranking translated into cytoprotection of 
peripheral neuronal precursors from high glucose insult. All plant organs, needles, bark and 
cone, conferred this protection, but it was sometimes dependent upon growth environment 
and habitat. For instance organ specificity was observed in that protection in coastal 
environments was only significant for bark and not needles. Again in coastal conditions, 
cytoprotection of bark extracts were stronger when source material was harvested from 
forests rather than bogs. This disproves our H2 hypothesis that bog environments would 
have stronger activities than forest habitats. Likely the compounds that are protective in the 
PC12 bioassays are not triggered by stresses from low levels of nutrients or acidic 
conditions characteristic of bogs (Zoltai and Vitt, 1995). Further studies which quantify 
environmental fluctuations between the two habitats would be necessary for comparison to 
biologically active phytochemical fluctuations to determine specific cause and effect 
conclusions. The findings from chapter three therefore hold significance in the field of 
ethnobotany as well as chemical ecology.  
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The differences highlighted in the bioassays were predicted to exist by the Elders. 
This emphasizes the importance of following up on the guidance of community members in 
these types of study projects and holds relevance for any situation in which people are 
trying to incorporate traditional medicines into  clinics. Further, variations highlighted here 
underline the importance of conducting similar experiments tailored to the biology of any 
plant being proposed for incorporation. Specifically for Picea mariana, the next step will 
be to further evaluate its active compounds and drug interaction biology in vitro as well as 
its overall bioactivity in vivo (Tam et al., 2009). Thus far we have identified pungenin in 
the needles and stillbene like compounds in the bark but we still need to examine their 
bioactivity. Total phenolic content and its associated antioxidant strength has also been 
evaluated but only the phenolic content held a direct correlation to bioactivity. One of the 
shortcomings of this study would be the lack of an in depth phytochemical analysis, which 
would be necessary for standardization and validation purposes. It should, however, be 
reiterated that it is not the goal of TAAM to develop alternative medicines or 
pharmaceuticals. However, it has been left open to the Cree of Eeyou Istchee to determine 
if steps will be taken towards the development of plant remedies for this purpose.  
Several elders have expressed willingness and interest in the widespread use of 
resulting remedies. Emphasis has been that the development of any alternative medicine for 
the Cree or other peoples should be done similarly in respect of the traditional knowledge 
and related ideals. Picea mariana could accommodate distribution outside of Eeyou Istchee 
populations as there is a wealth of resources to draw from in the North American boreal 
forests. These forests cover six million square kilometres and are dominated primarily by 
black spruce (Begin and Filion, 1999; Karst, 2010). As needle, bark and cone all conferred 
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protection at small concentrations, this represents a large quantity of available plant 
material. Furthermore this abundance of material would make the development of 
sustainable harvesting possible and as we already have a model in Pycnogenol®, it should 
be easier to put into practice (Rohdewald, 2002).  
For the time being observational studies that follow healer treatment of diabetic 
volunteers in Mistissini are taking place. In vitro results like the Picea mariana study serve 
to translate the efficacy of the plants chosen by the Cree healers. Thus far healer centered 
treatment in which solely healers administer traditional medicine is the goal, however it is 
important to realize this is the ideal situation. Without the training of new traditional 
practitioners within the participating communities healer centered treatment can only last as 
long as the existing healers are able to practice. Despite renewed interest in traditional 
medicine within the communities (personal communication), time is running out and there 
are only a few traditional practitioners and many patients. It is likely that the double burden 
of teaching new practitioners and treating patients is too much for already ageing healers. 
For this reason alternative forms of plant based medicine based on traditional practice 
become more important and it is necessary that through these studies we garner the trust of 
health care practitioners.  In any case, whether it be in the form of healer consultation or 
delivery by a health care practitioner the hope is that these treatments improve the quality 
of life in these communities by providing culturally appropriate holistic diabetes 
management.  
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Figure 2.5 Two dimensional (3rd and 4th dimension) scatter plot resulting from the correspondence analysis of 
plant species mentioned in Waskaganish interviews (1-12) and diabetes symptoms (A-O). Symptoms and 
species which are close to one another are closely associated. Plant species; 1. Abies balsamea, 2. Populus
balsamifera, 3. Picea mariana, 4. Thuja occidentalis, 5. Heracluem maximum, 6. Alnus incana spp. rugosa, 7. 
Pinus banksiana, 8. Rhododendron groenlandicum, 9. Sorbus decora, 10. Sarracenia purpurea, 11. Larix 
laricina, 12. Picea glauca. Symptoms; A. Increased Thirst, B. Urination, C.Increased Appetite, D.Weakness, 
E.Slow Healing Infections, F.Blurred Vision, G.Foot sores/numbness, H.Diarrhea, I.Rheumatism/Arthritis, 
J.Heart and/or Chest Pain, K.Inflammation, L.Sore/Swollen limbs, M.Headache, N.Back and/ or kidney Pain, O. 
Abscesses and/or Boils 
xviii


AppendixIII
 
Figure 2.6 Two dimensional scatter plot (2nd and 3rd dimension) resulting from the correspondence analysis of plant species 
mentioned in Nemaska interviews(1-10) and diabetes symptoms (A-O). Symptoms and species which are close to one 
another are closely associated. Plant species;1. Abies balsamea, 2. Populus balsamifera, 3. Picea mariana, 4. Alnus incana 
ssp. rugosa, 5. Pinus banksiana, 6. Rhododendron groenlandicum, 7. Sorbus decora, 8. Kalmia angustifolia, 9. Larix laricina, 
10. Picea glauca. Symptoms; A. Increased Thirst, B. Urination, C.Increased Appetite, D.Weakness, E.Slow Healing 
Infections, F.Blurred Vision, G.Foot sores/numbness, H.Diarrhea, I.Rheumatism/Arthritis, J.Heart and/or Chest Pain, 
K.Inflammation, L.Sore/Swollen limbs, M.Headache, N.Back and/ or kidney Pain, O. Abscesses and/or Boils 
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Figure 2 (A-D). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled needle extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (21) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; needle (N). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. 
Student t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 2 (E-H). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled needle extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (21) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; needle (N). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A 
students t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 2 (I-L). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled needle extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (21) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; needle (N). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A 
students t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 2 (M-P). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled needle extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (21) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; needle (N). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A 
students t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 2 (Q-T). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled needle extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (21) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; needle (N). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A 
students t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration).  
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Figure 3 (A-D). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled bark extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (14) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; bark (B). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A 
students t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 3 (E-H). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled bark extracts from 
forest and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from 
coastal west (1) to inland east (14) with forest (F) and bog (B) populations next to one another for comparison. Organ type is 
specified as the last number in the code; bark (B). Therefore each graph has a code identifying population number, habitat 
type and organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures 
mitochondrial dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) 
and compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A 
students t-test was used in order to determine the significant difference between the normoglucose control (100%) and the 
high glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare 
the % viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. 
Differences were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 3 (I). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled bark extracts from forest 
and bog populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from coastal west 
(1) to inland east (14) with forest (F) and bog (B) populations next to one another for comparison. Organ type is specified as 
the last number in the code; bark (B). Therefore each graph has a code identifying population number, habitat type and 
organ type above it in that order. Bioactivity was assessed using the formazan dye WST which measures mitochondrial 
dehydrogenase activity. Treatment wells containing extract were standardized to the normoglucose control (C) and 
compared to this and the high glucose control (HG) for the determination of protective, mitogenic or toxic effects. A students 
t-test was used in order to determine the significant difference between the normoglucose control (100%) and the high 
glucose control (56.799%, n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare the % 
viability for each concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. Differences 
were deemed significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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Figure 4 (A-F). Comparison of cytoprotective, mitogenic and cytotoxic activities of P. mariana pooled cone extracts from bog 
populations in a PC12-AC model of high glucose stress. Populations are listed in ascending order from coastal west (3) to 
inland east (15) Habitat is the second letter in the code (bog=B) while Organ type is specified as the last number in the code 
(cone=C). Therefore each graph has a code identifying population number, habitat type and organ type above it in that order. 
Bioactivity was assessed using the formazan dye WST which measures mitochondrial dehydrogenase activity. Treatment 
wells containing extract were standardized to the normoglucose control (C) and compared to this and the high glucose 
control (HG) for the determination of protective, mitogenic or toxic effects. A students t-test was used in order to determine 
the significant difference between the normoglucose control (100%) and the high glucose control (56.799%, 
n=54wells/condition, bar graph, p0.05). Anova analysis was employed in order to compare the % viability for each 
concentration 0.25, 0.50, 1.00 and 2.00ug/ml to the normoglucose and high glucose controls. Differences were deemed 
significant (*cytoprotection, #mitogenic) when p0.05 (n=3 treatment wells/concentration). 
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ID Voucher Date
Waskaganish  
WAS001 Thujaoccidentalis July132008
WAS002 Populusbalsamifera July122008
seefieldvouchers Piceamariana 
WAS004 Alnusincanaspp.rugosa Aug102008
WAS005 Heracleummaximum Aug62008
WAS006 Sorbussp. Aug102008
WAS007 Larixlaricina Aug102008
WAS008 Rhododendrongroenlandicum Aug102008
WAS009 Pinusbanksiana Aug112008
WAS010 Piceaglauca Aug112008
WAS011 Abiesbalsamea Aug132008
WAS012 Sarraceniapurpurea Aug152008
 
Nemaska  
NEM001 Rhododendrongroenlandicum Aug202008
NEM002 Pinusbanksiana Aug202008
seefieldvouchers Piceamariana 
NEM003 Alnusincanaspp.rugosa Aug202008
seeWaskaganish Abiesbalsamea 
NEM004 Larixlaricina Aug212008
notfound Vacciniumvitisidaea 
seeWaskaganish Populusbalsamifera Aug202008
NEM006 Kalmiaangustifolia Aug202008
NEM007 Sorbussp. Aug212008
seeWaskaganish Piceaglauca 
 
*Herbarium accession numbers and collection dates for voucher specimens from Waskaganish and Nemaska interviews. 
Three vouchers of each type share the same ID code but are labeled A, B or C (ie NEM001-A). Specimens are kept at the 
Marie Victorin Herbarium, Université of Montréal (MT) 
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ID Voucher Date 
Picea mariana field sites 
PM013 Bog 1 Aug 14 2008 
PM014 Forest 1 Aug 14 2008 
lost Bog 2 Aug 10 2008 
lost Forest 2 Aug 10 2008 
PM003 Bog 3 Aug 11 2008 
PM004 Forest 3 Aug 11 2008 
PM009 Bog 4 Aug 13  2008 
PM010 Forest 4 Aug 13  2008 
PM011 Bog 5 Aug 13  2008 
PM012 Forest 5 Aug 13  2008 
PM007 Bog 6 Aug 12  2008 
PM008 Forest 6 Aug 12  2008 
PM005 Bog 7 Aug 12  2008 
PM006 Forest 7 Aug 12  2008 
PM033 Bog 8 Aug 26 2008 
PM034 Forest 8 Aug 26 2008 
PM031 Bog 9 Aug 25 2008 
PM032 Forest 9 Aug 25 2008 
PM019 Bog 10 Aug 21 2008 
PM020 Forest 10 Aug 21 2008 
PM015 Bog 11 Aug 19 2008 
PM016 Forest 11 Aug 19 2008 
PM017 Bog 12 Aug 21 2008 
PM018 Forest 12 Aug 21 2008 
PM025 Bog 13 Aug 23 2008 
PM026 Forest 13 Aug 23 2008 
PM023 Bog 14 Aug 23 2008 
PM024 Forest 14 Aug 23 2008 
PM021 Bog 15 Aug 22 2008 
PM022 Forest 15  Aug 22 2008 
PM027 Bog 16 Aug 24 2008 
PM028 Forest 16 Aug 24 2008 
PM029 Bog 17 Aug 24 2008 
PM030 Forest 17 Aug 24 2008 
PM035 Bog 18 Aug 28 2008 
PM036 Forest 18 Aug 28 2008 
PM037 Bog 19 Aug 29 2008 
xxiv
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
PM038 Forest 19 Aug 29 2008 
PM039 Bog 20 Aug 30 2008 
PM040 Forest 20 Aug 30 2008 
PM041 Bog 21 Aug 30 2008 
PM042 Forest 21 Aug 30 2008 
 
*Herbarium accession numbers and collection dates for voucher specimens from field sites where Picea marians was 
collected for PC12 bioassays. Specimens are kept at the Marie Victorin Herbarium, Université of Montréal (MT) 
 
